Introduction {#s1}
============

In vertebrates, the vascular and immune systems constitute the only classes of cells that come into close proximity to nearly all other cell types in the body. These systems also share the property that a small number of basic cell types are further divided into functionally and molecularly distinct subtypes, some of which are specialized for the tissues in which they reside. For example, in the immune system, phagocytic cells are represented by monocytes in the blood, Kupffer cells in the liver, microglia in the central nervous system (CNS), Langerhans cells in the skin, and osteoclasts in bone. In the vascular system, organ-specific molecular and cellular specialization is typically at the level of microvascular (capillary) endothelial cells (ECs) ([@bib3]; [@bib4]; [@bib112]). Additional specializations, which apply across all tissues, distinguish arteries, veins, and capillaries.

Liver and brain capillaries exemplify two extremes of EC specialization. The highly permeable sinusoidal vascular endothelium of the liver acts as a sieve in which ECs form a discontinuous lining to allow efficient diffusional exchange between serum and hepatocytes. Hepatic capillaries also exhibit one of the body's highest capacities for endocytosis through the expression of various classes of scavenger receptors ([@bib4]; [@bib65]; [@bib110]). In contrast, the vast majority of capillaries in the CNS have extremely low permeability. CNS ECs are characterized by reduced transcytosis, an absence of fenestrations, tight junctions between neighboring cells, and a variety of small molecule transporters and efflux pumps ([@bib172]). Together, these properties constitute the blood-brain barrier (BBB).

The widespread functional, morphological, and molecular heterogeneity of ECs must ultimately reflect different gene expression programs. The BBB program represents a particularly interesting case, as it involves the coordinated regulation of a large number of genes ([@bib30]). Early transplantation studies showed that the BBB properties of CNS ECs are induced by developing neural tissue ([@bib137]), implicating an instructive signal from surrounding parenchyma. More recent work has shown that WNT and NORRIN ligands produced by neurons and glia activate receptors on ECs, and the resulting canonical Wnt signal initiates and maintains the BBB state ([@bib81]; [@bib135]; [@bib29]; [@bib156]; [@bib175]; [@bib21]). Interestingly, the same canonical Wnt signal acts earlier in vascular development to direct CNS angiogenesis.

Most molecular studies of EC heterogeneity have focused on defining transcriptome differences between EC subtypes ([@bib20]; [@bib30]; [@bib101]; [@bib58]). Several recent studies have also investigated the enhancer landscape of ECs ([@bib39]; [@bib54]; [@bib114]; [@bib173]). However, there have been no genome-wide analyses that integrate and compare the transcriptome, chromatin structure, and DNA methylation landscapes of ECs. Accessible chromatin and genomic regions with low levels of CG methylation are of particular interest as they mark candidate *cis*-regulatory elements (CREs) ([@bib133]; [@bib150]; [@bib136]; [@bib176]). Importantly, CG hypomethylation can also provide a record of a cell's developmental history, offering an opportunity to identify lineage-specific regulators ([@bib56]; [@bib98]; [@bib97]).

Here, we explore transcriptome, chromatin, and DNA methylation differences among four populations of murine ECs to determine the factors that are associated with EC heterogeneity. We uncover unique sets of candidate CREs that define different EC subtypes, and we identify candidate transcription factor (TF) regulators using motif enrichment analysis of these regions. We provide evidence for precisely spaced and oriented ETS and ZIC TF motifs that likely play a role in defining the enhancer landscape of brain ECs. To explore intra-tissue EC heterogeneity, we apply RNA profiling of brain ECs at the single-cell level, leading to a molecular definition of the relationship among the major CNS EC subtypes. Together, these studies provide an integrated view of the genetic and epigenetic mechanisms underlying the unique tissue-specific programs of EC differentiation.

Results {#s2}
=======

Tissue-specific endothelial cell gene expression {#s2-1}
------------------------------------------------

To characterize the genetic basis of inter-tissue heterogeneity among ECs, we set out to acquire a broad view of their genomic and epigenomic differences. Toward this end, we isolated ECs from four different murine tissues - brain, liver, lung, and kidney - at postnatal day 7 (P7) and performed RNA-seq, MethylC-seq ([@bib83]), and ATAC-seq ([@bib11]) to generate an atlas of transcript abundances, single-base resolution DNA methylation, and accessible chromatin, respectively ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). The data are available for public exploration as the Vascular Endothelial Cell Trans-omics Resource Database (VECTRDB) at <https://markfsabbagh.shinyapps.io/vectrdb/> and [https://github.com/mfsabbagh/EC_Genomics](https://github.com/mfsabbagh/EC_Genomics.). To visualize the data on a genome browser, see [http://neomorph.salk.edu/Endothelial_cell_methylome.php](http://neomorph.salk.edu/Endothelial_cell_methylome.php.). At P7, the vasculature is still growing but it has also, presumably, acquired tissue-specific properties to support organ function. To isolate ECs, we harvested organs from *Tie2-GFP* (the *Tie2* gene is also known as *Tek*) mice, which specifically express green fluorescent protein (GFP) in ECs ([@bib99]), enzymatically dissociated the tissues into single-cell suspensions, and then purified ECs using fluorescence-activated cell sorting (FACS) ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). This approach to EC isolation was optimized and validated by [@bib30]). We note that *Tie2-GFP* is not expressed in all ECs. For example, we could not detect GFP in the capillaries of renal glomeruli by immunostaining (yellow arrows in [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Each high-throughput sequencing experiment was performed on two or more independent biological replicates, and these exhibited high pairwise correlations ([Figure 1A](#fig1){ref-type="fig"} and far right panel of [Figure 1B](#fig1){ref-type="fig"}; [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}, [3](#fig1s3){ref-type="fig"} and [4A](#fig1s4){ref-type="fig"}; [Figure 2A](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}).

![RNA-seq reveals inter-tissue EC heterogeneity.\
(**A**) Genome browser images showing CG methylation (top) and RNA expression (bottom) for two genes: *Slc2a1*, a glucose transporter expressed in brain ECs, and *Fabp4*, a fatty acid binding protein expressed in liver and kidney ECs. For DNA methylation, the mCG/CG ratio is shown, with the height of each bar indicating the fractional methylation (range: 0 to 1). For RNA-seq, histograms of the number of aligned reads are shown. For this and all other genome browser images, the heights of all the tracks of a given sequencing experiment are the same across samples. For both genes, tissue-specific gene expression is associated with tissue-specific hypomethylation near the TSS. Red arrows indicate illustrative examples of differential hypomethylation. Br, brain; Li, liver; Lu, lung; Ki, kidney. R1 and R2, biological replicates. Black arrows beneath this and all other genome browser images indicate the direction of transcription. (**B**) Scatter plots comparing cross-sample normalized RNA-seq read counts of EC-expressed protein-coding genes from brain versus liver, lung, and kidney, showing only those transcripts with TPM \>10 for each of the two RNA-seq replicates. Colored symbols indicate transcripts with FDR \< 0.05 and enrichment \>2 fold for the indicated tissue comparison. Right, comparison of cross-sample normalized RNA-seq read counts for protein-coding genes between the two brain EC replicates. Values depicted are the log~2~ transformation of cross-sample normalized counts + 1. (**C**) Heatmaps depicting transcript abundances for 739 Endothelial Cell Tissue-Specific Genes (ECTSGs). Left, log~2~ transformation of TPM +1. Right, z-scores for the TPMs. (**D**) Principal component analysis of all EC-enriched transcripts from brain, liver, lung, and kidney. The two symbols for each sample represent biological replicates. In this and all other figures, tissue type is indicated by color: Br, brain, blue; Li, liver, cyan; Lu, lung, magenta; Ki, kidney, green.](elife-36187-fig1){#fig1}

![MethylC-seq reveals distinct classes of hypomethylated regions in ECs.\
(**A**) Scatter plots comparing the mean fraction of CG methylation in a 5 kb window immediately 3' of the TSS for protein-coding genes from brain ECs versus liver, lung, and kidney ECs. Colored symbols indicate transcripts with FDR \< 0.05 and enrichment \>2 fold for the indicated tissue comparison. These plots show a positive correlation between EC tissue-specific gene expression and tissue-specific hypo-methylation. Right, comparison of CG methylation between the two brain EC biological replicates. (**B**) Heatmap indicating the percentage of each row that overlaps with differentially expressed genes. A significant proportion of ECTS-large hypo-DMRs overlap differentially expressed genes for the same EC-subtype relative to the other EC subtypes. Black stars indicate statistical significance at q \< 1×10^−10^. (**C**) Heatmap indicating the percentage of each row that overlaps with either ECTS-large hypo-DMRs or DMVs. DMVs exhibit more overlap between EC subtypes than large hypo-DMRs. (**D**) Genome browser images showing methylation as in [Figure 1A](#fig1){ref-type="fig"} at various TF genes. Colored bars indicate DMVs. Each genome browser image is at the same scale.](elife-36187-fig2){#fig2}

To filter out non-EC transcripts that derive from lysed parenchymal cells, we also conducted RNA-seq on GFP-negative FACS-sorted cells, and, for completeness, total dissociated tissue. By comparing the expression profiles of GFP-positive cells to GFP-negative cells, we determined a union set of 4117 protein-coding and non-coding EC-enriched transcripts from each tissue for further analysis ([Supplementary file 2](#supp2){ref-type="supplementary-material"}; see the RNA-seq section under Materials and methods for the three criteria applied in this comparison). Importantly, this list contains many known EC markers, including *Pecam1*, *Kdr*, *Cdh5*, and *Tek* (also known as *Tie2*). Notably absent from the list are the pan-leukocyte marker *Ptprc/Cd45*, the macrophage/microglia marker *Csf1r*, the vascular smooth muscle cell marker *Acta2*, the pericyte marker *Cspg4*, and various abundant parenchyma-specific markers such as *Syt11* (brain), *Alb* (liver), *Sftpc* (lung), and *Umod* (kidney) ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). The GFP-negative fraction of dissociated liver was unexpectedly depleted for hepatocyte-specific transcripts suggesting that hepatocytes were lost during cell dissociation and/or flow cytometry. This fraction was enriched for transcripts associated with Kupffer cells (*Cd68*, *Cd80*, and *Cd86*) and cholangiocytes (*Epcam*, *Pkhd1l1*, and *St14*; [@bib79]) ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). Based on the retention of known EC-specific transcripts and the removal of known parenchyma-specific transcripts, we conclude that the EC-enrichment criteria selected for bona fide EC-specific transcripts.

Focusing only on the 3853 protein-coding EC-enriched transcripts, scatter plots of between-sample normalized RNA-seq read counts for ECs from one tissue versus the three other EC subtypes show both previously identified and novel tissue-specific EC markers ([Figure 1B](#fig1){ref-type="fig"}; [Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}). In this analysis, the relatively low correlation between different tissue EC transcriptomes reflects the exclusion of housekeeping genes. Brain ECs specifically express mRNAs coding for transporters such as *Mfsd2a*, *Slc2a1*, and *Slco1c1* ([Figure 1B](#fig1){ref-type="fig"}, first three panels), whereas liver sinusoidal ECs specifically express mRNAs coding for scavenger receptors such as *Fcgr2b*, *Stab2*, and *Clec4g* ([Figure 1B](#fig1){ref-type="fig"}, first panel). Similarly, mRNA coding for angiotensin-converting enzyme (*Ace*), a known lung EC marker, was specifically enriched in lung ECs ([Figure 1B](#fig1){ref-type="fig"}, second panel). The differential expression analysis also identified two novel lung EC markers, *Scn7a* and *Scn3b* ([Figure 1B](#fig1){ref-type="fig"}; [Figure 1---figure supplements 3B](#fig1s3){ref-type="fig"} and [4B](#fig1s4){ref-type="fig"}). The former is a sodium channel referred to as Na(x) that is responsive to extracellular levels of sodium and that was previously reported to be expressed in lung epithelium ([@bib157]; [@bib158]; [@bib166]), while the latter is an auxiliary beta subunit that can modify the conductance of sodium channel alpha subunits ([@bib28]). *Ctfr*, the cystic fibrosis transmembrane conductance regulator, and surfactant proteins *Sftpa1*, *Sftpb*, *Sftpc*, and *Sftpd* exhibit enrichment in the lung GFP-negative fraction, consistent with a known lung epithelial role for these genes ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}). In contrast, both *Scn7a* and *Scn3b* show a clear enrichment in lung ECs on par with *Ace* enrichment, implying that they function in ECs rather than in the epithelium ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}). We speculate that expression of *Scn7a* and *Scn3b* may allow lung ECs to directly sense serum sodium concentration, perhaps to regulate *Ace* expression and thereby provide feedback control of the renin-angiotensin-aldosterone system.

Transcripts from 2392 genes exhibited \>2 fold differential abundance between one or more pairs of EC subtypes, with 739 exhibiting \>2 fold differential expression in a comparison of ECs from one tissue versus ECs from each of the other three tissues ([Figure 1C](#fig1){ref-type="fig"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"}; see Materials and methods). We will refer to these 739 genes as 'EC-tissue-specific genes' or 'ECTSGs'. For reference, this abbreviation and those that follow are summarized and defined in [Table 1](#table1){ref-type="table"}. Of the 739 ECTSGs, 685 are protein-coding and 54 are non-coding. Gene ontology (GO) enrichment analysis ([@bib8]; [@bib147]; [@bib147]) of the four sets of ECTSGs was consistent with tissue-specific specializations of each vascular bed. For example, brain ECTSGs were enriched for GO terms such as 'neutral amino acid transport' and 'drug transmembrane transport' whereas liver ECTSGs were enriched for GO terms such as 'scavenger receptor activity' and 'vesicle-mediated transport' ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Consistent with the known role of Wnt signaling in brain endothelium development, brain ECTSGs were also enriched for the GO term 'negative regulation of canonical Wnt signaling pathway' ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). Principal component analysis (PCA) of the four EC transcriptomes showed that the transcriptional signatures of brain ECs and liver ECs are substantially distinct from each other and from those of lung ECs and kidney ECs ([Figure 1D](#fig1){ref-type="fig"}), broadly consistent with earlier studies of embryonic and adult ECs ([@bib30]; [@bib58]).
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###### Abbreviations used throughout the text

  Abbreviation    Definition
  --------------- -------------------------------------------------
  ATAC            Assay for Transposase Accessible Chromatin
  BBB             Blood-brain barrier
  CRE             *Cis*-regulatory element
  DEG             Differentially expressed gene
  DMR             Differentially methylated region
  DMV             DNA methylation valley (UMR \> 3 kb)
  EC              Endothelial cell
  ECTS-hypo-DMR   Endothelial cell tissue-specific hypo-DMR
  ECTSAP          Endothelial cell tissue-specific ATAC-seq peak
  ECTSG           Endothelial cell tissue-specific gene
  GO              Gene ontology
  LMR             Low-methylated region (hypomethylated, CG-poor)
  PCA             Principal component analysis
  scRNA-seq       Single-cell RNA-seq
  TF              Transcription factor
  TSS             Transcription start site
  UMR             Unmethylated region (hypomethylated, CG-rich)

Identification of distinct classes of hypomethylated regions in endothelial cells {#s2-2}
---------------------------------------------------------------------------------

Low cytosine DNA methylation (mCG) immediately downstream of transcriptional start sites (TSSs) typically correlates with increased gene expression ([@bib128]). In visually comparing EC methylation profiles to transcription profiles, we find that differentially expressed genes are often associated with tissue-specific hypomethylation starting at the TSS and extending into the gene body ([Figure 1A](#fig1){ref-type="fig"}). As a result, plotting the mean fraction of mCG methylation in a five kilobase (kb) window downstream of the TSS for all protein-coding genes reveals an inverse relationship between methylation and gene expression among differentially expressed EC-enriched genes ([Figure 2A](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). However, these differences in methylation at differentially expressed genes occur in the context of highly similar global methylation patterns, as seen by correlation coefficients between different EC subtypes (0.95--0.97) that are nearly indistinguishable from the correlation coefficients between biological replicates (0.95--0.98; [Figure 2A](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}).

The distinctive tissue-specific patterns of ECTSGs imply that ECs regulate transcription with a corresponding set of tissue-specific CREs. \[Although the use of the term 'CRE' implies that these non-coding genomic regions influence nearby genes (i.e. act in cis), we recognize that some of these genetic elements may act between chromosomes (i.e. in trans).\] To identify candidate EC CREs based on patterns of DNA methylation, we first parsed individual EC DNA methylomes into unmethylated regions (UMRs; hypomethylated, CG-rich) and low-methylated regions (LMRs; hypomethylated, CG-poor). These criteria were based on those of [@bib133] and [@bib13], with some modifications (e.g. methylation threshold *m* \< 0.3; see Materials and methods) to account for a relatively low level of global CG methylation (mean of 67%). We identified 16,158 brain EC, 16,506 liver EC, 16,171 lung EC, and 15,979 kidney EC UMRs (median length = 1738 bp; median mCG = 10%), and 72,061 brain EC, 60,212 liver EC, 57,594 lung EC, and 71,343 kidney EC LMRs (median length = 490 bp; median mCG = 15%) ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). 72% of the UMRs (12,581 of 17,406) are within 2 kb of a TSS whereas only 5.7% of the LMRs (6682 of 116,273) are within 2 kb of a TSS ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), consistent with an earlier study showing that UMRs are enriched at promoters and LMRs are enriched at distal regulatory elements ([@bib133]). 86% of UMRs (15,036 of 17,406) are shared by all four EC subtypes, whereas only 25% of LMRs (29,053 of 116,273) are shared by all four EC subtypes ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}).

We next searched for regions of the genome that were differentially hypomethylated in one or more pairwise comparisons among the four EC subtypes. Unlike the enumeration of UMRs/LMRs, which is an intrinsic property of each DNA methylome, this analysis relies on a comparison between DNA methylomes. Using a conservative statistical approach ([@bib82]); see Materials and methods), we discovered 105,050 discrete differentially hypomethylated regions ('hypo-DMRs'; i.e., a % mC difference above threshold in one or more pairwise comparisons between EC tissue types; median length = 228 bp) with the largest number present in liver ECs (42,682), followed by lung ECs (32,004), brain ECs (30,471), and kidney ECs (17,027). A smaller number of hypo-DMRs were uniquely hypomethylated in one EC tissue type (25,612 in liver ECs, 13,862 in lung ECs, 16,540 in brain ECs, and 7132 in kidney ECs). We will refer to these regions as 'EC-tissue-specific hypo-DMRs' or 'ECTS-hypo-DMRs' ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Almost all hypo-DMRs (94.5%) are found \>2 kb from a TSS, suggesting they reflect distal regulatory elements ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). This pattern of EC tissue-type diversity among hypo-DMRs and LMRs implies differential utilization of the enhancer landscape.

A previous study in neurons has shown that many closely spaced hypo-DMRs are part of larger hypomethylated regions that correlate with the current transcriptional state of a cell and with higher levels of histone modifications associated with active enhancers ([@bib98]). Therefore, we expanded our analysis to assess regions of low DNA methylation that span multiple kilobases. Using an approach similar to the one described by [@bib98]), we merged closely spaced (separation \<1 kb) hypo-DMRs into larger hypomethylated regions; we refer to such regions as 'large hypo-DMRs' if they are \>2 kb in size ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). ECTS-large hypo-DMRs are enriched at differentially expressed EC-enriched genes (q-value \<10^−10^; [Figure 2B](#fig2){ref-type="fig"}; see [Supplementary file 5](#supp5){ref-type="supplementary-material"}).

DNA methylation valleys (DMVs; also referred to as DNA methylation canyons) are a distinct category of large hypomethylated regions that exhibit especially high enrichment at genes coding for important regulators of embryonic development including many TFs ([@bib163]; [@bib60]; [@bib98]; [@bib97]). Defining DMVs as UMRs \> 3 kb, we identified 2313 brain EC, 2695 liver EC, 2403 lung EC, and 2208 kidney EC DMVs ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). We found very little overlap between large hypo-DMRs and DMVs, implying they represent distinct hypomethylated features ([Figure 2C](#fig2){ref-type="fig"}). These two categories of hypomethylation are further distinguished by the extent to which they are shared between EC types: 1602 DMVs are shared by all four EC subtypes and additional DMVs are shared between subsets of EC subtypes, whereas the majority of large hypo-DMRs are specific to a single EC subtype ([Figure 2C](#fig2){ref-type="fig"}). We used the Genomic Regions Enrichment of Annotations Tool (GREAT) to identify gene ontologies associated with EC DMVs ([@bib93]). Consistent with previous studies in other tissues ([@bib163]; [@bib60]; [@bib98]; [@bib97]), EC DMVs are highly enriched for genes encoding TFs ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}).

Previously identified DMVs in embryonic stem cells (ESCs) remain hypomethylated after cellular differentiation, with only a small subset demonstrating DNA methylation variations across cell types ([@bib163]). These large regions of hypomethylation are maintained by Polycomb complexes that deposit repressive H3K27me3 histone modifications and are thought to support developmental plasticity, as DNA methylation may reflect a more stable repressive mechanism ([@bib80]). Interestingly, a subset of H3K27me3-positive DMVs found at lineage-specific expressed genes exhibit increased DNA methylation outside of the promoter region with a corresponding loss of H3K27me3, providing a snapshot of the developmental history of gene expression ([@bib80]). In all four subtypes of ECs, DMVs overlap *Etv2*, *Foxc2*, *Tal1*, *Lmo2*, *Id3,* and *Fli1*, genes coding for TFs that are important for establishing the EC lineage ([Figure 2D](#fig2){ref-type="fig"}). DMVs are also present at *Sox7*, *Hey1*, and *Nr2f2*, TFs important for venous or arterial differentiation. An exception to this pattern is seen with the early embryonic TF gene *Pou5f1/Oct4*, which lacks a DMV, consistent with a previous report that this locus exhibits increased DNA methylation upon cell differentiation ([@bib163]). No EC DMVs overlap *Gata1* and *Spi1*, which are important for establishing the erythroid and myeloid/lymphoid lineages, respectively. Given that ECs and hematopoietic cells share the same developmental lineage, these observations suggest that DMVs occur at TFs that determine very early progenitor cell lineage commitments. Curiously, EC DMVs overlap some genes coding for lineage-determining TFs in completely unrelated cell types, including oligodendrocytes (*Olig1* and *Olig2)* and Muller glia (*Lhx2*) ([Figure 2D](#fig2){ref-type="fig"}).

At genes coding for TFs that are differentially expressed among EC subtypes, DMVs show EC subtype-specific differences in boundary locations and degree of methylation, with a broad trend of increased methylation 5' of the TSS in the EC subtype(s) that express the TF gene as seen for *Foxf1*, *Foxf2*, and *Zic3* in brain; *Tbx3* in brain, lung, and kidney; *Tbx2*, *Gata6*, *Meis1*, and *Meis2* in liver, lung, and kidney; *Gata4* in liver; and *Irx3* in kidney ([Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}). This observation is consistent with a proposed model in which cell-type-specific expression of important TF regulators of lineage identity results in nearby hypermethylation ([@bib80]). We note that FOXF1, a lung EC-enriched TF implicated in pulmonary vascular development ([@bib62]; [@bib16]; [@bib35]), represents an exception to this methylation pattern, due to demethylation at the adjacent lung EC-expressed lncRNA gene, *Fendrr* ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}).

HOX gene expression and DNA methylation: correlation with anterior-posterior position {#s2-3}
-------------------------------------------------------------------------------------

Some of the largest regions of hypomethylation are found in the HOX gene clusters. HOX genes do not exhibit the classic relationship between methylation and gene expression ([@bib75]; [@bib10]; [@bib163]). Among the four EC subtypes, HOX cluster DNA methylation is lowest in brain ECs, intermediate in liver and lung ECs, and highest in kidney ECs ([Figure 3A and C](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This pattern of methylation correlates with the anterior/posterior position of the brain, liver, lung, and kidney -- as well as with their embryonic primordia - along the body axis: the brain is most anterior, the lungs and liver are intermediate (and are derived from the primitive foregut), and the kidneys are the most posterior (and are derived from the ureteric bud and surrounding mesenchyme). For all four HOX clusters, the ATAC-seq patterns are similar for liver, lung, and kidney ECs, but the peak intensities are greatly reduced in brain ECs ([Figure 3A](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

![In ECs, patterns of methylation and gene expression at HOX gene clusters correlate with anterior/posterior position.\
(**A**) Genome browser image showing CG methylation (top) and accessible chromatin (bottom) at the HOX-A gene cluster. HOX genes in this cluster are expressed in an anterior-posterior gradient corresponding to their position in the cluster, with genes near the 3' end of the cluster expressed more anteriorly and genes near the 5' end expressed more posteriorly. The degree of EC methylation is: brain \<liver \~ lung\<kidney. The degree of EC accessible chromatin is: brain \<liver \< lung\~kidney. Colored bars indicate DMVs or ATAC-seq peaks. Red arrows pointing down indicate illustrative examples of differential hypomethylation. Red arrows pointing up indicate illustrative examples of differential hypermethylation. (**B**) Expression levels (TPMs) based on RNA-seq for each gene in the HOX-A cluster. (**C**) Heatmap depicting mean fraction of methylated CG across each HOX cluster for each EC subtype. (**D**) Heatmaps depicting log~2~(TPM +1) or mean fraction of methylated CG in the gene body for genes within each of the four HOX clusters.](elife-36187-fig3){#fig3}

In the HOX clusters, there is a roughly co-linear relationship between each gene's position along the chromosome and the anterior/posterior territory along the body axis where that HOX gene is expressed: genes that are named with low numbers (e.g. *Hoxa1*) are expressed more anteriorly and genes that are named with high numbers (e.g. *Hoxa13*) are expressed more posteriorly ([@bib77]; reviewed in [@bib104]). Based on the EC subtype-specific RNA-seq data, we found that patterns of HOX gene expression correlate with the anterior/posterior position of each organ and its corresponding EC subtype ([Figure 3B and D](#fig3){ref-type="fig"}). In the HOX-A cluster, brain ECs express none of the *Hoxa* genes; liver ECs express *Hoxa2--Hoxa5*; lung ECs express *Hoxa2--Hoxa5* and *Hoxa7*; and kidney ECs express *Hoxa5* and *Hoxa7-Hoxa10*, with lower levels of expression in *Hoxa2-Hoxa4*. ([Figure 3B and D](#fig3){ref-type="fig"}). Interestingly, there does not appear to be a strong relationship between gene expression and gene body methylation (compare top and bottom heatmaps in [Figure 3D](#fig3){ref-type="fig"}). Rather, like other developmentally important TFs, the trend is that expression of a HOX gene correlates with increased methylation in the neighborhood of the gene body. For example, *Hoxa5* which is expressed in liver, lung, and kidney ECs but not brain ECs exhibits a hypomethylated gene body in all ECs but a hypermethylated promoter region only in peripheral ECs ([Figure 3A](#fig3){ref-type="fig"}). Similarly, the regions in and adjacent to *Hoxa10* are hypermethylated only in kidney ECs, which are the only ECs in this set that express *Hoxa10* ([Figure 3A](#fig3){ref-type="fig"}). For each of the four organs, the patterns of EC and parenchymal cell expression of *Hoxa* genes are closely matched ([Figure 3B](#fig3){ref-type="fig"}). These data confirm and extend two earlier studies: (1) a microarray transcriptome meta-analysis showing a correlation between patterns of HOX gene expression and the tissue-of-origin for a collection of human EC lines ([@bib151]) and (2) a transgenic mouse study showing that *Hoxa3* and *Hoxc11* reporter expression in murine vasculature roughly corresponds to the positional identity specified by the HOX code ([@bib113]). Taken together, the patterns of HOX gene expression and DNA methylation suggest that ECs in different organs 'know' their anterior-posterior position within the body.

Comparisons between accessible chromatin and hypomethylation landscapes {#s2-4}
-----------------------------------------------------------------------

As a second and complimentary approach to defining candidate EC CREs, we analyzed regions of accessible chromatin. In our initial analysis, we used the full range of ATAC-seq fragment lengths and identified a total of 51,740 discrete regions of accessible chromatin (i.e. ATAC-seq peaks; median length 656 bp) among the four EC subtypes ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). Across replicates, the percent of mapped reads found in called peaks ranged between 16 and 34% ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Calling peaks on subsamples of total mapped reads for each ATAC-seq replicate indicates that, with this sequencing depth, the data is approaching an asymptote ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). In deriving a consensus EC-tissue-specific peakset, we adopted a conservative approach by requiring each peak to be called in 2/2 or 2/3 replicates ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}).

For a quantitative assessment of open chromatin, we restricted our analyses to ATAC-seq fragments of \<100 bp, as previous work suggested that these correspond to nucleosome-free regions of the genome ([@bib11]). Using \<100 bp fragments, we identified a total of 39,987 ATAC-seq peaks (median length 508 bp) among the four EC subtypes ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). \[Hereafter, the phrase 'ATAC-seq peaks' refers to \<100 bp fragments unless otherwise stated.\] Of the 31,358 brain EC, 18,926 liver EC, 24,970 lung EC, and 21,694 kidney EC ATAC-seq peaks, 35% are shared across all four EC subtypes, but only 1--16% are EC subtype-specific (6381 brain, 632 liver, 755 lung, and 397 kidney EC-tissue-specific ATAC-seq peaks, referred to hereafter as 'ECTSAPs') ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}).

We observed multiple ECTSAPs near ECTSGs, as illustrated in [Figure 4A](#fig4){ref-type="fig"} using the full range of ATAC-seq fragment lengths. As indicated by the translucent orange bars in [Figure 4A](#fig4){ref-type="fig"}, ECTS-hypo-DMRs generally co-localize with ECTSAPs. For example, near brain EC-specific genes *Slc2a1* and *Mfsd2a*, multiple ECTSAPs and ECTS-hypo-DMRs co-localize ([Figure 4A](#fig4){ref-type="fig"}, upper two panels; [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). Similarly, the genomic region encompassing *Clec4g*, a liver EC-specific gene, contains co-localized ECTSAPs and ECTS-hypo-DMRs upstream and downstream of the gene body ([Figure 4A](#fig4){ref-type="fig"}, right bottom panel; [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). A region \~200 kb upstream of *Foxf1* contains two ECTSAPs that colocalize with ECTS-hypo-DMRs ([Figure 4A](#fig4){ref-type="fig"}, left bottom panel; [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}), suggestive of a long-range enhancer. This region also includes a lncRNA gene, *Gm26878*, that is expressed specifically in lung ECs ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). In [Figure 4A](#fig4){ref-type="fig"}, regions of chromatin accessibility and hypomethylation that are shared across more than one EC subtype are indicated by translucent gray bars.

![Accessible chromatin and hypomethylated regions reveal candidate EC regulatory elements.\
(**A**) Genome browser images showing CG methylation (top) and accessible chromatin (bottom) around ECTSGs. Colored bars under mCG tracks mark UMRs (upper row) and LMRs (lower row). For accessible chromatin, histograms of ATAC-seq reads are shown. Colored bars under ATAC tracks indicate the called ATAC-seq peaks. Vertical orange bars highlight co-localizing cell-type-specific open chromatin and differentially hypomethylated DNA. Vertical gray bars highlight shared regions of open chromatin in at least three EC subtypes. The ATAC-seq reads shown here represent the full range of ATAC-seq fragment sizes. (**B**) Scatter plots of normalized ATAC-seq read density (**N**) within ATAC-seq peaks called from \<100 bp fragments. Values shown are log~2~(N + 1). Colored symbols correspond to peaks for which the closest annotated TSS is a differentially expressed EC-enriched gene from the indicated tissue. Lower right, comparison between two brain EC ATAC-seq biological replicates. (**C**) Pairwise Pearson correlation heatmaps for ATAC-seq read density within ATAC-seq peaks at promoter-proximal (\<2 kb from TSS; upper left) or promoter-distal (\>2 kb from TSS; upper right) and percent CG methylation in UMRs (lower left) and LMRs (lower right).](elife-36187-fig4){#fig4}

In scatter plots of normalized ATAC-seq read densities, ECTSAPs for each tissue type are enriched near differentially expressed EC-enriched genes for that tissue ([Figure 4B](#fig4){ref-type="fig"}), and broad differences are apparent between EC subtypes (r = 0.75--0.92), whereas biological replicates of the same subtype are highly similar (r = 0.93--0.97, [Figure 4B](#fig4){ref-type="fig"}; [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Additionally, a larger proportion of ECTSAPs and ECTS-hypo-DMRs are within 100 kb of ECTSGs that are expressed in the corresponding EC subtype relative to ECTSGs expressed in the other EC subtypes, a difference that is highly significant statistically ([Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}). This enrichment implies a role for these candidate CREs in EC subtype-specific gene expression.

Of the 39,987 total ATAC-seq peaks among all four EC subtypes, 64% are \>2 kb from a TSS (i.e. are promoter-distal). Similar to the distributions described above for UMRs and LMRs, a majority of promoter-proximal (\<2 kb from a TSS) ATAC-seq peaks are shared by all EC subtypes (10,336 of 14,474; 71%), whereas only a small minority of promoter-distal ATAC-seq peaks are shared by all EC subtypes (3476 of 25,517; 14%) ([Figure 4C](#fig4){ref-type="fig"}, upper two panels; [Figure 4---figure supplement 2D](#fig4s2){ref-type="fig"}). This trend is even more striking for methylation at UMRs and LMRs ([Figure 4C](#fig4){ref-type="fig"}, lower two panels). Chromatin accessibility at UMRs and LMRs and DNA methylation at ATAC-seq peaks similarly shows greater divergence among EC subtypes at distal candidate CREs ([Figure 4---figure supplement 2E](#fig4s2){ref-type="fig"}). The ATAC-seq comparisons also reveal a greater degree of similarity in chromatin accessibility among ECs derived from the three peripheral tissue (liver, lung, and kidney) relative to brain ECs ([Figure 4C](#fig4){ref-type="fig"}). Taken together, these comparisons suggest that the heterogeneity in gene expression that gives rise to tissue-specific EC differentiation may largely reflect differences in distal rather than proximal CREs. As illustrated by the hierarchical clustering analysis shown in [Figure 4C](#fig4){ref-type="fig"}, these differences are most pronounced in the case of brain ECs, a finding that potentially reflects the specialized and extensive program of gene expression associated with the BBB.

In all four EC subtypes, \>80% of ATAC-seq peaks overlap with UMRs or LMRs ([Figure 4---figure supplement 4A](#fig4s4){ref-type="fig"}), in agreement with previous findings in neurons and photoreceptors ([@bib98]; [@bib97]). ATAC-seq peaks from all four EC subtypes exhibit similarly reduced levels of DNA methylation compared to random size-matched genomic regions. Moreover, ECTSAPs exhibit levels of DNA methylation that are preferentially reduced in their respective EC DNA methylomes ([Figure 4---figure supplement 4B](#fig4s4){ref-type="fig"}). Reciprocally, there were preferential increases in the EC subtype-specific ATAC-seq signal in the respective ECTS-hypo-DMRs ([Figure 4---figure supplement 4C](#fig4s4){ref-type="fig"}).

Interestingly, there are many more LMRs than ATAC-seq peaks, and therefore only a minority of LMRs overlap with ATAC-seq peaks:\<10% of liver EC and kidney EC LMRs and \<20% of brain and lung EC LMRs overlap with ATAC-seq peaks ([Figure 4---figure supplement 4A](#fig4s4){ref-type="fig"}). In contrast, \>75% of UMRs overlap with ATAC-seq peaks in all four EC subtypes. In comparing ECTS-hypo-DMRs and ECTSAPs, \<5% of liver EC, lung EC, and kidney EC hypo-DMRs overlap with their respective ATAC-seq peaks, whereas 13% of brain EC hypo-DMRs overlap with brain ATAC-seq peaks. As two explanations for this numerical difference, we suggest either (1) that many distal enhancer regions may not exhibit a sufficient degree of chromatin accessibility to permit insertion by two transposon complexes, the requisite event for detection of DNA accessibility by ATAC-seq, or (2) that distal enhancer regions may have greater variance in their occupancy across the population of cells, resulting in a general decrease in average accessibility.

Tissue-specific EC transcription factors and their DNA targets {#s2-5}
--------------------------------------------------------------

If LMRs and ATAC-seq peaks mark CREs, then they should be enriched for the DNA binding motifs of the TFs that control the distinct transcriptional, chromatin, and DNA methylation landscapes observed in ECs from different tissues. Current models of transcriptional regulation posit that TFs act in a combinatorial fashion, co-localizing at CREs to give rise to cell-type-specific transcription ([@bib50]; [@bib51]). These models predict that CREs in different EC subtypes should (1) share motifs corresponding to TFs that orchestrate patterns of gene expression common to all ECs, and (2) exhibit subtype-specific motifs corresponding to TFs that orchestrate patterns of gene expression distinctive to each EC subtype.

To investigate these models, we used Hypergeometric Optimization of Motif EnRichment (HOMER), a suite of tools for discovering enriched motifs in genomic sequences ([@bib49]). The HOMER de novo motif detection strategy parses genomic sequences under consideration into all possible k-mers of a desired motif length and searches for enrichment of each k-mer, a strategy that is not dependent on existing biochemical definitions of TF motifs ([Figure 5A](#fig5){ref-type="fig"}). The results of the k-mer analysis are then compared to a compendium of known TF motifs. HOMER also directly searches the genomic sequences under consideration for known TF motifs ([Figure 5B](#fig5){ref-type="fig"}). In general, we found the two approaches to be in good agreement.

![Motif enrichment analysis identifies candidate TF regulators of tissue-specific EC development and function.\
(**A**) HOMER-identified enriched motifs in ECTS-hypo-DMRs. Frequency of the indicated motif as a function of distance from the center of ECTS-hypo-DMRs. Shown above each individual plot is the position weight matrix (PWM) of the enriched nucleotide sequence. The TF family that most closely matches the motif is indicated below the PWM. (**B**) Heatmap showing the fold enrichment for the indicated TF motifs (% ECTSAPs or ECTS-hypo-DMRs containing the motif divided by % GC-matched background genomic regions containing the motif). Representative members of TF families that exhibited a significant enrichment (FDR \< 0.001) are shown. (**C**) Heatmap showing TPMs for the four EC subtypes for a subset of TFs with the motifs shown in (**A**). Values shown are log~2~(TPM +1). (**D**) ECTS-hypo-DMRs were centered on the motif for ERG, a member of the ETS family, and the frequencies of the indicated motifs were plotted as a function of distance from the ERG motif with a bin size of 1 bp. Black arrow: the ZIC motif ends with the sequence AGG and the ERG motif begins with the sequence AGG, thereby generating a frequency spike in all four EC subtypes at position −5 bp that represents the overlap of the two sites. Red arrow: the frequency spike for the ZIC motif at +11 bp is only present in one orientation and only in brain ECTS-hypo-DMRs centered on the ERG motif. (**E**) PWM for the consensus sequence of the paired ETS:ZIC motif. (**F**) Representative instances of the paired ETS:ZIC motif from brain ECTS-hypo-DMRs. Each instance is represented by a black rectangle. The bottom strand of the sequence in (**F**) matches the consensus sequence shown in (**E**).](elife-36187-fig5){#fig5}

To address the first prediction, we first identified LMRs and ATAC-seq peaks that are not present in photoreceptors and brain neurons ([@bib98]; [@bib97]). This should filter out CREs associated with 'housekeeping' genes, thereby enriching for CREs that reflect the EC regulatory landscape. This procedure identified 56,755 LMRs and 12,200 ATAC-seq peaks that are relatively EC-specific ([Supplementary files 4](#supp4){ref-type="supplementary-material"} and [6](#supp6){ref-type="supplementary-material"}). From this subset, 8035 LMRs and 899 ATAC-seq peaks were common to all four EC subtypes. Analyzing this common subset using HOMER revealed a highly significant (LMRs: p-value=10^−1691^; ATAC-seq peaks: p-value=10^−148^) enrichment over random GC-matched genomic regions for a sequence that resembles the binding motif of class 1 members of the ETS family of TFs, which includes ERG, FLI1, ETV2, and ETS1 ([@bib159]; [@bib55]); [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). The finding of a common enriched class 1 ETS family motif is not unexpected given the large body of data supporting a role for class 1 ETS TFs in EC development and function ([@bib92]; [@bib107]; [@bib94]; [@bib103]; [@bib140]). We also detected k-mers matching the SOX (p-value=10^−101^) and GATA (p-value=10^−94^) binding motifs in shared EC-only LMRs and - unexpectedly - a k-mer matching the telomere sequence TTAGGG (p-value=10^−123^) in shared EC-only ATAC-seq peaks ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}).

To address the second prediction, we used HOMER to search for TF motifs in sequences present in the four sets of ECTSAPs and the four sets of ECTS-hypo-DMRs. In addition to the EC subtype-specific enriched motifs described in the paragraphs below, this analysis revealed the class 1 ETS motif in both ECTSAPs (p-value=10^−45^--10^−718^) and ECTS-hypo-DMRs (p-value=10^−30^--10^−1169^) ([Figure 5A and B](#fig5){ref-type="fig"}). This observation suggests that ETS family TFs not only act in shared CREs to determine and maintain common aspects of the EC phenotype, but they also cooperate with EC subtype-specific TFs in EC subtype-specific CREs. As determined from the EC RNA-seq datasets, all four subtypes of ECs express members of the ETS family of TFs, including ERG, FLI1, and ETS1 ([Figure 5C](#fig5){ref-type="fig"}). As seen in [Figure 5B](#fig5){ref-type="fig"}, the motif analysis using ECTSAPs was in good agreement with the motif analysis using ECTS-hypo-DMRs, but the latter exhibited a higher signal-to-noise ratio, most likely due to the larger number of ECTS-hypo-DMRs.

Significantly, HOMER identified several EC subtype-specific enriched motifs ([Figure 5A and B](#fig5){ref-type="fig"}). As different members of a given TF family generally recognize the same or nearly the same motif, we determined which family members are likely to be relevant for tissue-specific EC transcriptional regulation by assessing their transcript abundances in the EC RNA-seq datasets ([Figure 5C](#fig5){ref-type="fig"}). A summary of motifs and TFs for each of the four EC subtypes follows (see also [Supplementary file 7](#supp7){ref-type="supplementary-material"}).

\- In brain ECTS-hypo-DMRs, we identified enriched k-mers that closely match the motifs of the Forkhead box (FOX), TCF/LEF, and ZIC TF families ([Figure 5A](#fig5){ref-type="fig"}). Transcripts corresponding to three *Fox* family members (*Foxq1*, *Foxc1*, and *Foxf2*), two *Tcf/Lef* family members (*Tcf7* and *Lef1*), and the *Zic* family member *Zic3* were highly enriched in brain ECs ([Figure 5C](#fig5){ref-type="fig"}). LEF/TCF family members are the effectors of canonical Wnt signaling in the nucleus ([@bib15]). The specific enrichment of LEF/TCF motifs in brain ECTS-hypo-DMRs and ECTSAPs is consistent with previous evidence that canonical Wnt signaling in ECs plays a central role in CNS angiogenesis and BBB development and maintenance, but that it has little or no role in vascular development outside of the CNS ([@bib81]; [@bib135]; [@bib29]; [@bib156]; [@bib175]; [@bib21]). The brain EC-specific enrichment of ZIC motifs is consistent with previous work showing that the accumulation of ZIC3 in the developing retinal vasculature depends on NORRIN/FRIZZLED4 (i.e. canonical Wnt) signaling ([@bib156]). Analysis of candidate CREs near the *Zic3* gene in all four EC subtypes revealed the presence of a brain ECTSAP \~50 kb downstream of the gene that contains ETS and TCF/LEF binding sites, suggestive of a nearby Wnt-responsive enhancer element (translucent orange bar in [Figure 5---figure supplement 2A and B](#fig5s2){ref-type="fig"}).

\- In liver ECTS-hypo-DMRs, we identified enriched k-mers that closely match the motifs recognized by members of the GATA and MAF TF families ([Figure 5A](#fig5){ref-type="fig"}). RNA-seq across the four EC populations showed that *Gata4* and *Maf* have the greatest enrichment among members of their respective families in liver ECs ([Figure 5C](#fig5){ref-type="fig"}). Consistent with these observations, a recent study found that GATA4 controls liver EC development and function ([@bib45]). In liver ECTS-hypo-DMRs, we also detected enrichment for a k-mer that corresponds to the NR2F2/COUP-TFII motif ([Figure 5A](#fig5){ref-type="fig"}). As NR2F2/COUP-TFII is essential for establishing venous EC identity ([@bib169]), enrichment of this motif could reflect enrichment of venous ECs due to inclusion of the portal vein and its tributaries or a bona fide role for NR2F2 in liver sinusoid development. Like *Gata4* and *Maf*, *Nr2f2* transcripts are enriched in liver ECs ([Figure 5C](#fig5){ref-type="fig"}).

\- In lung ECTS-hypo-DMRs, we identified enriched k-mers that closely match the motifs of the FOX, GATA, and homeobox TF families ([Figure 5A](#fig5){ref-type="fig"}). *Foxp1*, *Foxm1*, *Foxf1*, *Gata2*, *Gata3*, *Gata6*, and *Hoxa5* transcripts are enriched in lung ECs ([Figure 5C](#fig5){ref-type="fig"}).

\- In kidney ECTS-hypo-DMRs, we identified enriched k-mers that closely match the homeobox motif ([Figure 5A](#fig5){ref-type="fig"}). RNA-seq shows strong kidney-specific enrichment for homeobox transcripts *Irx3*, *Hoxa7*, *Pbx1*, and *Meis2* ([Figure 5C](#fig5){ref-type="fig"}). A motif corresponding to anterior HOX proteins (e.g. HOXA2; [Figure 5B](#fig5){ref-type="fig"}) was enriched in lung and kidney whereas a motif corresponding to posterior HOX proteins (e.g. HOXC9; [Figure 5B](#fig5){ref-type="fig"}) showed enrichment primarily in kidney, consistent with the *Hox* gene expression patterns described above ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

If the enriched motifs play a role in regulating EC subtype-specific gene expression, then one might expect an enrichment for the same motifs in candidate EC subtype-specific CREs near ECTSGs in one EC subtype relative to candidate CREs near ECTSGs in other EC subtypes. Consistent with this expectation, ECTS-hypo-DMRs found within 100 kb of ECTSGs exhibit statistically significant enrichment for most of the motifs in [Figure 5A](#fig5){ref-type="fig"} ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). ECTSAPs within 100 kb of ECTSGs were also significantly enriched for several of these motifs ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} shows five examples of individual ECTSGs and their nearby candidate CREs with tissue-specific TF and ETS motifs marked in the regions encompassed by ECTS-hypo-DMRs and ECTSAPs ([Figure 5---figure supplement 2C--F](#fig5s2){ref-type="fig"}; data are shown for Zic3 and for the four genes shown in [Figure 4A](#fig4){ref-type="fig"}).

Identification of a paired ETS and ZIC motif with precise spacing and orientation {#s2-6}
---------------------------------------------------------------------------------

If ETS TFs, which are expressed in all ECs, cooperate with tissue-specific EC TFs to control expression of ECTSGs, then there might be a non-random spatial relationship between ETS motifs and motifs for tissue-specific TFs. To test this idea, we compiled all of the ECTS-hypo-DMRs containing an ERG (i.e. ETS family) motif, aligned these ECTS-hypo-DMRs on the ERG motif, and then generated, for each of the four EC subtypes, motif frequency histograms with a 1 bp bin size for the lung EC-enriched FOXF1 motif, the liver EC-enriched GATA4 motif, the kidney EC-enriched HOXC9 motif, the brain EC-enriched ZIC3 and TCF/LEF motifs as a function of distance from the center of the ERG motif ([Figure 5D](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}).

From this analysis, two general patterns emerged. One pattern is exemplified by the frequency of GATA4 motifs in liver ECTS-hypo-DMRs, which are modestly enriched within \~40 bp of the ERG motif. This suggests that in liver ECs GATA4 may collaborate with ERG and/or other class 1 ETS factors but without forming a unique ETS-GATA4-DNA ternary complex. The second pattern is exemplified by the spatial relationship between the ERG and ZIC3 motifs. Here, we observed a spike in ZIC3 motif frequency precisely 2 bp from the end of and in the same orientation as the ERG motif only in brain ECTS-hypo-DMRs (red arrow in [Figure 5D](#fig5){ref-type="fig"} lower right panel). A partial overlap of the ERG and ZIC3 motifs (the nucleotide sequence AGG occurs at the start of the ERG motif and at the end of the ZIC3 motif) generates a second spike in ZIC3 motif frequency that is present in all four EC subtypes but is unlikely to be of biological significance (black arrow in [Figure 5D](#fig5){ref-type="fig"} lower right panel). Additional correlations are observed between the ERG motif and FOXF1 and HOXC9 motifs in lung and kidney ECTS-hypo-DMRs, respectively (red arrows in [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). The paired FOX:ETS motif in lung ECTS-hypo-DMRs matches a composite FOX:ETS motif found in several EC-specific enhancers that is known to be bound and synergistically activated by FOX and ETS factors ([@bib33]; [@bib122]). The paired ETS:HOX motif in kidney ECTS-hypo-DMRs suggests a similar interaction between ETS factors and HOX factors; however, we found no previous characterization of such an interaction in the literature. A partial overlap of the nucleotide sequence AGG between the TCF/LEF motif and the ERG motif generates a spike in frequency that is present in all four EC subtypes but is unlikely to be of biological significance (black arrow in [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}).

The proximity, precise spacing, and orientation of the ERG and ZIC3 motifs in brain ECTS-hypo-DMRs suggests that these two transcription factors form a ternary complex by binding to this larger DNA element. To determine a consensus for this element, we repeated the HOMER analysis on brain ECTS-hypo-DMRs with longer motifs. This analysis revealed a consensus motif that we will refer to as the paired ETS:ZIC motif ([Figure 5E](#fig5){ref-type="fig"}; [Supplementary file 7](#supp7){ref-type="supplementary-material"}). Strikingly, identically spaced ETS and ZIC motifs lead to robust enhancer activity in the ascidian *Ciona,* implying an ancient and conserved role for the cooperation of ETS factors and ZIC factors in transcriptional regulation ([@bib41]). Genome-wide, there are only 1944 instances of the paired ETS:ZIC motif, and this paired motif is significantly enriched in candidate brain EC CREs (both hypo-DMRs and ATAC-seq peaks) relative to random GC-matched genomic regions (DMR p-value=10^−45^; ATAC peak p-value=10^−17^) and to peripheral EC CREs (DMR p-value=10^−74^; ATAC peak p-value=10^−7^; [Figure 5F](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}). Interestingly, 81% of the brain EC CREs that contain one or more paired ETS:ZIC motifs overlap the long terminal repeats (LTRs) of the mouse-specific endogenous retrovirus (ERV) family RLTR45/ERVB4_2. Transposable elements, especially LTR retrotransposons, provide a rich genomic substrate for the evolution of non-coding regulatory elements ([@bib38]; [@bib25]; [@bib24]); reviewed in [@bib148]). We speculate that RLTR45/ERVB4_2 may represent an example of a transposable element family that is being co-opted into host gene regulatory networks that utilize ETS and ZIC factors.

Canonical Wnt signaling in CNS ECs versus non-CNS ECs {#s2-7}
-----------------------------------------------------

At present, it is not known whether CNS EC-specific effects of canonical Wnt signaling reflect a spatial restriction on Wnt signaling - perhaps reflecting the spatial distribution of the relevant ligands - or whether canonical Wnt signaling occurs throughout the vasculature but has different downstream consequences in CNS and non-CNS tissues. To address this question, we visualized canonical Wnt signaling at cellular resolution in CNS and non-CNS vasculature using an EC-specific Cre recombinase (*Tie2-Cre*) and a Cre-dependent Wnt reporter (*R26-Tcf/Lef-LSL-H2B-GFP-6xMYC*). With this combination of genetic elements, Cre-mediated excision of a *loxP*-flanked transcription stop cassette allows the multimerized LEF/TCF motifs, together with a minimal promoter, to report canonical Wnt signaling by controlling production of a nuclear-localized histone H2B-GFP-6xMYC fusion protein specifically in ECs ([@bib21]).

In coronal sections of E13.5 embryos, the pan-EC TF ERG and the pan-EC plasma membrane protein ICAM2 mark all ECs ([Figure 6A and A'](#fig6){ref-type="fig"}). At this stage, BBB development is already underway, as judged by the accumulation of the glucose transporter GLUT1/SLC2A1, a BBB marker, specifically in CNS and perineural ECs ([Figure 6B and B'](#fig6){ref-type="fig"}). At E13.5, ZIC3 accumulation in the vasculature is also limited to CNS and perineural ECs ([Figure 6C and C'](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), a distribution that closely matches that of GLUT1/SLC2A1. Outside of the vasculature, ZIC3 accumulates in developing neurons in the ventral CNS. Similarly, vascular accumulation of LEF1, which is both a mediator and a marker of canonical Wnt signaling, is limited to CNS and perineural ECs ([Figure 6---figure supplement 2A and A'](#fig6s2){ref-type="fig"}). Visualizing the accumulation of the Wnt reporter, H2B-GFP-6xMYC, with anti-MYC immunostaining shows a neural and perineural distribution, closely matching that of SLC2A1, ZIC3, and LEF1 ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We note that cells positive for the Wnt reporter occur outside of the CNS, yet their rounded morphology and lack of association with blood vessels suggests that these cells are macrophages or other immune cells, consistent with the specificity of *Tie2-Cre*. At P7, H2B-GFP-6xMYC accumulates in CNS ECs, as well as ECs in the renal medulla ([Figure 6---figure supplement 2B--E](#fig6s2){ref-type="fig"}), and ZIC3 and SLC2A1 are restricted to the CNS vasculature (data not shown). These protein distributions are consistent with the CNS EC-specific expression of *Lef1* and *Zic3* found by RNA-seq ([Figure 5C](#fig5){ref-type="fig"}) and the CNS EC-enrichment of TCF/LEF and ZIC3 motifs in ECTS-hypo-DMRs ([Figure 5A and B](#fig5){ref-type="fig"}). Taken together, these data imply that, among ECs, canonical Wnt signaling is largely confined to the CNS, with a corresponding restriction in the expression of TFs that mediate (LEF1) and respond to (LEF1 and ZIC3) canonical Wnt signaling.

![Canonical Wnt signaling in CNS but not peripheral ECs at E13.5.\
(**A--C**) Coronal sections of E13.5 *Tie2-Cre;R26-Tcf/Lef-LSL-H2B-GFP-6xMYC* embryos near the cephalic flexure. The markers are: ICAM2 (pan-EC membrane protein), MYC (the canonical Wnt reporter), ERG (pan-EC TF), SLC2A1 (the glucose transporter GLUT1; a BBB marker), ZIC3, and DAPI. (**A'--C'**) Higher magnification of the boxed regions in (**A--C**). The boundary between CNS and peripheral tissue is marked on the DAPI image with red circles. The nuclear MYC signal reveals canonical Wnt signaling in CNS ECs (yellow arrows) but not in peripheral ECs (yellow arrowheads). ZIC3 is present in CNS ECs (yellow arrows) but not in peripheral ECs (yellow arrowheads), and in developing neurons in the ventral CNS. Scale bars in A, B, and C: 200 um. Scale bars in A', B', and C': 50 um.](elife-36187-fig6){#fig6}

Single-cell RNA-seq reveals heterogeneity among brain ECs {#s2-8}
---------------------------------------------------------

Up to this point, the focus has been on EC heterogeneity between tissues. Here, we address the question of intra-tissue EC heterogeneity. It is well established that arterial, venous, and capillary ECs represent distinct subtypes based on morphology, function, and gene expression profiles ([@bib3]; [@bib112]), but it is not clear whether or to what extent these EC subtypes can be further subdivided. It is also not clear how developing EC subtypes, such as tip cells and proliferating cells, are related to the more mature EC subtypes. To address these questions, we assessed EC gene expression in the developing CNS at single-cell resolution by performing single-cell RNA-seq (scRNA-seq) on 3,946 FACS-purified GFP-positive ECs from a P7 *Tie2-GFP* mouse brain.

scRNA-Seq data were processed and analyzed using a modified dpFeature approach as described in the Monocle R/Bioconductor package ([@bib152]). t-Distributed Stochastic Neighbor Embedding (t-SNE) of cells revealed a single interconnected distribution of gene expression profiles suggesting a continuity of transcriptional identity across brain ECs at this developmental time point consistent with the observed zonation of EC subtypes along the vasculature. Subsequent clustering analysis identified six EC clusters ([Figure 7A](#fig7){ref-type="fig"}) that could be assigned as tip, mitotic, venous, or arterial cells (one cluster each) or capillary cells (two adjacent clusters) based on known EC subtype marker gene expression ([Figure 7B](#fig7){ref-type="fig"}). One of the capillary clusters is enriched for cells expressing *DOPA Decarboxylase* (*Ddc*), a gene known to be expressed in ECs in bovine aorta ([@bib130]). The ECs in the high-*Ddc* cluster also express multiple genes that are characteristic of arterial ECs and this cluster was therefore named 'capillary-A' (capillary-arterial). The second capillary cluster was relatively deficient in *Ddc*-expressing cells, and it was enriched for cells that express genes characteristic of venous ECs. The second cluster was therefore named 'capillary-V' (capillary-venous). Mitotic ECs express multiple genes that are also expressed in capillary-V and venous ECs ([Figure 7C](#fig7){ref-type="fig"}), which is consistent with the observation that proliferating cells arise from veins during sprouting angiogenesis ([@bib37]; [@bib164]; [@bib47]; [@bib109]). Capillary-A ECs express multiple genes that are also expressed in tip cells and arterial ECs, but tip cells and arterial ECs show less mutual similarity ([Figure 7C](#fig7){ref-type="fig"}).

![Single-cell RNA-seq of P7 brain ECs reveals intra-tissue heterogeneity.\
(**A**) t-SNE plot of 3946 P7 brain ECs showing six clusters corresponding to tip cells, and mitotic, venous, capillary-venous (Capillary-V), capillary-arterial (Capillary-A), and arterial ECs. (**B**) The t-SNE plot from (**A**) showing expression of three marker genes with enriched expression for each EC cluster. Cells with no RNA-seq reads are shown in light blue; darker blue represents greater number of reads. (**C**) Heatmap showing scaled expression (z-scores) for the 25 most enriched marker genes for each EC cluster. [Supplementary file 8](#supp8){ref-type="supplementary-material"} lists the genes plotted in (**C**). Rows represent genes and columns represent cells.](elife-36187-fig7){#fig7}

The distribution of DDC was examined by immunostaining of P7 WT mouse brain ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). DDC was localized to puncta, most likely corresponding to axon terminals of dopaminergic neurons; this pattern was particularly concentrated in the striatum, a brain region receiving dense dopaminergic innervation ([Figure 7---figure supplement 1C and D](#fig7s1){ref-type="fig"}). Most interestingly, we detected both fine- and coarse-grained heterogeneity in DDC immunostaining in GS Lectin-positive capillaries in different anatomic structures within the same brain sections, as seen by comparing the intensity of the general EC marker GS-Lectin and anti-DDC immunoreactivity. Larger vessels showed minimal DDC immunoreactivity (yellow arrows in [Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}). The heterogeneity in DDC immunoreactivity among capillary ECs likely corresponds to the differential capillary-A versus capillary-V gene expression patterns defined by scRNA-seq.

Although ECs within the six clusters express many genes in common, there were multiple genes expressed more or less selectively by each cluster ([Figure 7C](#fig7){ref-type="fig"}; [Supplementary file 8](#supp8){ref-type="supplementary-material"} lists the top 25 genes for each cluster). The identification of multiple new markers for tip cells is especially interesting as it substantially extends earlier screens for tip cell markers based on the overproduction of tip cells in Dll4^+/-^ mouse retinas and on laser capture microdissection ([@bib34]; [@bib138]). Five genes that were previously validated as tip cell markers in the retina --- *Plaur*, *Angpt2*, *Lcp2*, *Cxcr4*, *Apln,* and *Kcne3* --- are enriched in the scRNAseq tip cell cluster ([@bib34]; [@bib138]; [@bib117]). Interestingly, 19 of the 25 most enriched tip cell transcripts from the scRNA-seq analysis code for membrane or secreted proteins, many of which are known or suspected regulators of information flow. These include ion channels (the mechanosensor PIEZO2, voltage-gated sodium channel beta subunit SCN1B, and potassium channels KCNE3 and KCNA5), cell adhesion proteins (protocadherin PCDH17, cell adhesion molecules MADCAM1 and MCAM, and lectin CLEC1A), receptor tyrosine kinase signaling regulator SIRPA, G-protein-coupled receptor CMKLR1, plasminogen regulator SERPINE1/PAI, urokinase receptor PLAUR, ligands adrenomedullin (ADM) and ANGPT2, and ECM protein SMOC2. Among the six intracellular proteins in the list of top 25 tip cell markers, most are involved in signaling, including cyclic nucleotide phosphodiesterase 4B (PDE4B), serine/threonine phosphatase PPM1J/PP2C-zeta, NADPH oxidase organizer-1 (NOXO1), and the ubiquitin ligase HECW2, which regulates EC-EC junction stability via its substrate angiomotin-like-1 ([@bib23]).

To independently assess the expression of candidate tip cell genes, we performed whole mount in situ hybridization (ISH) on P5-7 retina ([Figure 8](#fig8){ref-type="fig"}). At this developmental stage, the vascular plexus on the vitreal face of the retina is growing outward from the optic disc and tip cells are localized to the growing vascular front. Consistent with the scRNA-seq analysis, *Apln*, *Mcam, Lamb1,* and *Trp53i11* exhibited enriched expression at the angiogenic front of the superficial vascular plexus ([Figure 8A--D](#fig8){ref-type="fig"}), indicating tip cell enrichment of these genes. As a specificity control, *Tm4sf1* exhibited only arterial expression by both scRNA-seq analysis and whole mount retina ISH ([Figure 8E](#fig8){ref-type="fig"}).

![Single-cell RNA-seq of P7 brain ECs identifies novel tip cell markers.\
(**A--E**) Whole mount retina in situ hybridization (ISH) for known tip cell marker *Apln* (**A**); novel tip cell markers *Mcam* (**B**), *Lamb1* (**C**), and *Trp53i11* (**D**); and a novel arterial marker *Tm4sf1* (**E**). The first two columns, from left to right, are the t-SNE plot from [Figure 7A](#fig7){ref-type="fig"} showing expression of each marker gene and a low-magnification merged image of flatmount retina with blood vessels marked by GS Lectin (magenta) and ISH signal (green). The third to fifth columns showed the boxed region in column two at higher magnification, with separate signals (columns three and four) and the merged signals (column five). All scale bars are 50 um.](elife-36187-fig8){#fig8}

To describe the relationships between the six EC clusters, the scRNA-seq data were used to construct a cell trajectory map ([Figure 9A](#fig9){ref-type="fig"}). This analysis produced a map with two branch points and four terminal states \[mitotic (M), venous (V), arterial (A), and tip cell (T)\]. Capillary-V and capillary-A ECs populate the regions adjacent to the first and second branch points, respectively. The first branch point represents a choice between the venous state and the arterial and tip-cell states, implying that, at the transcriptome level, tip cells are more closely related to arterial ECs than to venous ECs. As examples of gene expression patterns that support this model, *Hey1* is more highly expressed in arterial ECs and tip cells than in venous ECs, whereas *Nr2f2* is more highly expressed in mitotic and venous ECs than in arterial ECs or tip-cells ([Figure 9B](#fig9){ref-type="fig"}). The second branch point represents a choice between the arterial state and the tip-cell state. *Fbln2* and *Plaur* are examples of genes that are more highly expressed in arterial ECs and tip-cells, respectively ([Figure 9B](#fig9){ref-type="fig"}).

![Cell trajectory analysis of brain ECs based on single-cell RNA-seq.\
(**A**) Plot showing the position of cells in each EC cluster on the constructed cell trajectory. (**B**) Summary of the two branch points (labeled '1' and '2') in the cell trajectory analysis. M, mitotic; V, venous; A, arterial; T, tip cells. Examples of markers that show differential expression as cells diverge from branch points 1 and 2. Cells with no RNA-seq reads are shown in light blue; dark blue represents greater number of reads. Hey1 is enriched in arterial and tip cells (i.e. the products of the right side of branchpoint 1); Nr2f2 is enriched in venous ECs; Fbln2 is enriched in arterial ECs; and Plaur is enriched in tip cells.](elife-36187-fig9){#fig9}

Among the transcripts with intriguing differences between EC clusters were several coding for cyclin-dependent kinase (CDK) inhibitors. In particular, *Cdkn1c/p57* expression was enriched in artery and vein ECs; *Cdkn1a/p21* expression was enriched in mitotic cells, tip cells, and capillary-A ECs; and *Cdkn2b/p15* expression was enriched in capillary-A ECs ([Figure 9---figure supplement 1A](#fig9s1){ref-type="fig"}). *Cdkn1a/p21* expression suggests that these ECs have exited the cell cycle ([@bib131]). Interestingly, TGF-beta2 (*Tgfb2*) was widely expressed but Latent TGF-beta-binding protein 4 (*Ltbp4*) expression was concentrated in arterial ECs, which utilize TGF-beta signaling to coordinate vascular smooth muscle cell development ([@bib146]); [Figure 9---figure supplement 1A](#fig9s1){ref-type="fig"}). Transcripts coding for SMAD6 and SMAD7, two inhibitory SMADs induced by TGF-beta signaling ([@bib1]), were enriched in the capillary-A and arterial EC clusters ([Figure 9---figure supplement 1A](#fig9s1){ref-type="fig"}). Both CDKN1A and CDKN2B are known to mediate TGF-beta-induced cell cycle arrest ([@bib46]; [@bib31]), consistent with a role for TGF-beta signaling in CNS EC development.

We also observed enrichment of transcripts coding for the chemokine receptor CXCR4 in tip cell, capillary-A, and arterial EC clusters, consistent with the role of this receptor in mediating angiogenic sprouting and artery formation ([@bib138]; [@bib14]; [@bib37]; [@bib164]; [@bib47]; [@bib109]); [Figure 9---figure supplement 1A](#fig9s1){ref-type="fig"}). Transcripts coding for CXCL12, the ligand for CXCR4, were highly enriched in the arterial EC cluster, suggesting that tip cells in the developing brain vasculature may receive a CXCL12 signal from arterial ECs. CXCL12 is expressed in pulmonary and coronary arterial ECs, where it mediates patterning of arterial vasculature ([@bib19]; [@bib63]). Cell trajectory representations of CDK inhibitor, TGF-beta signaling, and CXCR4/CXCL12 transcripts are shown in [Figure 9---figure supplement 1B](#fig9s1){ref-type="fig"}.

Discussion {#s3}
==========

The experiments and analyses presented here define the transcriptome, accessible chromatin, and DNA methylome landscapes for ECs from brain, liver, lung, and kidney, and they relate differences in those landscapes to the regulatory programs that control tissue-specific EC heterogeneity. The resulting genome-wide analysis of candidate CREs, TF motifs, and TF expression reveal the distinctive gene regulatory architecture of each EC subtype. Using scRNA-seq, we define the relationships among developing and mature EC subtypes within the brain based on an unbiased clustering of gene expression profiles. In comparing CNS versus non-CNS ECs, the most prominent differences in TF motifs and TF expression include CNS EC-specific utilization of TCF/LEF and ZIC3 motifs and CNS EC-specific expression of TCF/LEF factors and ZIC3, implying a prominent role for canonical Wnt signaling and ZIC3 DNA binding in CNS EC-specific gene expression.

The DNA methylation landscape as a guide to current and past gene expression {#s3-1}
----------------------------------------------------------------------------

The relationship between patterns of mammalian DNA methylation and gene expression has been an object of inquiry for more than 40 years ([@bib120]; [@bib118]; [@bib6]). The discovery of diverse methyl CG binding proteins ([@bib129]) and the more recent characterization of DNA methylation effects on the binding affinities of diverse TFs ([@bib57]; [@bib67]; [@bib168]) imply that DNA methylation/demethylation can play a causal role in the control of chromatin state and the utilization of enhancers and promoters via its effects on protein binding. Reciprocally, changes in chromatin state and gene transcription can alter the accessibility of DNA to the enzymatic machinery of methylation and demethylation, leading to changes in DNA methylation ([@bib139]).

Comparative analyses of DNA methylation are especially powerful because technical developments now permit the genome-wide determination of DNA methylation at single-base resolution starting with small numbers of cells. Using this approach, we observe EC subtype-specific patterns of CG methylation that correlate with current patterns of gene expression and that also appear to reflect patterns of gene expression at earlier developmental points, especially at TF genes. As recognized in several previous studies, DNA methylation and gene expression do not exhibit a simple monotonic relationship ([@bib98]; [@bib5]; [@bib85]; [@bib100]). Many expressed genes exhibit promoter demethylation, with a variable degree of demethylation extending into the gene body. Demethylation can also reflect earlier epochs in which the gene was expressed, thus serving as a mnemonic epigenetic feature ([@bib56]; [@bib98]). Paradoxically, in the HOX cluster, methylation appears to correlate inversely with current gene expression: it is lowest among CNS ECs, which show little or no HOX gene expression, and it is highest among kidney ECs, which show the highest levels of HOX gene expression. This inverse correlation could reflect a loss (or retention) of the association of Polycomb repressive complexes with HOX clusters ([@bib40]; [@bib70]; [@bib74]), a resulting loss (or retention) of chromatin compaction ([@bib18]; [@bib44]; [@bib42]; [@bib102]), and a corresponding increase (or decrease) in access to DNA methyltransferases.

Previous work has linked DNA demethylation of promoter-distal regions with enhancers ([@bib133]; [@bib128]). In the present study, LMRs and ECTS-hypo-DMRs have been used to identify candidate CREs and enriched TF motifs. As many promoter-distal hypomethylated regions are differentially hypomethylated in one or more pairwise comparisons between EC subtypes, the availability of the complete DNA methylomes for brain, liver, lung, and kidney ECs provides a powerful resource for identifying candidate tissue-specific EC CREs. While promoter-distal ATAC-seq peaks generally co-localize with LMRs and/or ECTS-hypo-DMRs, promoter-distal hypomethylated regions are \~3 fold more numerous than promoter-distal regions of chromatin accessibility, and, as a result, TF motif enrichment analyses using hypomethylated regions provided greater statistical significance than the comparable analysis with accessible chromatin.

Rod photoreceptors exhibit a similar discrepancy in the number of promoter-distal hypomethylated features and accessible chromatin, and [@bib97] suggested that the degree of chromatin compaction associated with the extremely small nuclei of rods could restrict access of DNA methyltransferases to DNA. As they mature, EC nuclei flatten and elongate ([@bib17]; [@bib95]; [@bib106]), which enhances chromatin compaction ([@bib155]). Hence, it is not inconceivable that one of the explanations for the EC discordance between hypomethylated features and accessible chromatin may be EC nuclear structure.

Organ-specific regulatory circuits for EC gene expression {#s3-2}
---------------------------------------------------------

Current evidence suggests that all ECs differentiate from hemangioblasts, a common precursor to both the vascular EC and hematopoietic lineages. Restricted expression of lineage determining TFs directs a population of mesodermal cells away from the blood cell fate and toward the EC fate, giving rise to EC progenitors that express the vascular endothelial growth factor (VEGF) receptor KDR ([@bib90]; [@bib105]). In particular, the ETS factor ETV2 and the forkhead box factor FOXC2 cooperate to establish KDR +hemangioblasts ([@bib33]; [@bib142]; [@bib141]; [@bib105]). Continued expression of ETV2 and other ETS factors, including ERG, FLI1, and ETS1, together with GATA2 and FOXC2, commits these progenitors to the EC lineage ([@bib108]; [@bib84]).

Arterial-venous differentiation represents the earliest observable differentiation of blood vessels in embryonic development. This process occurs through extracellular cues that activate specific transcriptional regulatory networks (reviewed in [@bib112]). In particular, VEGF and Notch signaling drive arterial differentiation and gene expression through SOX factors ([@bib43]; [@bib26]; [@bib53]), whereas NR2F2-mediated suppression of Notch signaling establishes venous endothelium ([@bib169]). Although these more global EC transcriptional networks are well established, there remains a large gap in our understanding regarding the signaling pathways and transcriptional regulators that drive organ-specific EC identities.

In the present study, we provide transcriptional and epigenomic evidence for TFs that likely control tissue-specific specialization of ECs. For example, liver sinusoidal ECs exhibit differential expression of *Gata4* and *Maf* with a corresponding enrichment of GATA and MAF binding motifs in candidate CREs. Liver EC-specific deletion of *Gata4* leads to a conversion of sinusoidal endothelium to continuous endothelium similar to that found in brain vasculature ([@bib45]), and deletion of *Maf* globally results in a defective erythropoietic microenvironment in the liver ([@bib71]). Kidney ECs appear to utilize transcriptional networks that depend on homeobox TFs as seen by the enrichment of a HOX motif in kidney EC-specific CREs. Our observation that kidney ECs differentially express *Hoxa7, Pbx1*, and *Meis2* is consistent with a role for PBX and MEIS proteins as cofactors for HOX proteins ([@bib22]; [@bib86]; [@bib32]). PBX1 is also essential in the developing renal mesenchyme ([@bib127]), and its deletion in renal vascular mural cells leads to disrupted renal vascular development ([@bib59]). The data presented here imply that PBX1 also plays a role in kidney ECs. Similarly, *Irx3 -* another kidney EC-specific homeobox TF - was previously identified as a regulator of nephron segment identity in *Xenopus* ([@bib119]), and the data presented here imply that it also plays a role in kidney ECs. These observations suggest that shared expression of TFs in parenchymal cells and ECs in the same organ may be a not uncommon pattern.

Inter- and intra-tissue heterogeneity of vascular endothelial cells {#s3-3}
-------------------------------------------------------------------

The inter-tissue heterogeneity of EC structure and function has long been recognized as a central component of organ specialization ([@bib3]; [@bib4]). For example, in secondary lymphoid organs, leukocyte trafficking from the intravascular compartment to the surrounding parenchyma is mediated by leukocyte adhesion molecules on the luminal face of ECs in high endothelial venules (HEVs); in the kidney, serum filtration is controlled by ECs in renal glomeruli with a high density of fenestrations and a luminal glycocalyx that functions as a charge filter; in the liver, efficient detoxification of xenobiotics requires rapid equilibration of serum contents with hepatocytes, a process that is facilitated by ECs with large trans-cellular fenestrae; and in the lung, regulation of systemic blood pressure is controlled by EC expression of angiotensin-converting enzyme ([@bib9]).

For many tissues, culturing the resident ECs leads to a loss of tissue-specific EC markers, implicating paracrine signaling from the parenchyma in tissue-specific EC differentiation and maintenance. For example, HEV ECs isolated from human tonsils lose multiple tissue-specific markers after 2 days in culture ([@bib72]). In some systems, co-culture with parenchymal cells leads to retention of organ-specific markers: co-culture of cardiac ECs with cardiac myocytes induces expression of markers characteristic of cardiac microvascular ECs ([@bib2]), and co-culture of hepatic sinusoidal ECs with hepatocytes induces expression of markers characteristic of hepatic ECs ([@bib36]). With the exception of CNS ECs (discussed below), the identities of the organ-specific paracrine signals remain unknown.

The present genomic approach complements these foundational observations. Analyses of the transcriptome, accessible chromatin, and DNA methylome landscapes can be used to more precisely define organ-specific EC differentiation in vivo and in vitro, providing genomic snapshots of the different stages of EC differentiation, the effects of tissue-specific paracrine signals, and the response of ECs to disease-associated perturbations. With respect to the last point, this approach should prove especially interesting in dissecting the chromatin and epigenomic architecture of ECs within tumor vasculature, where a distinctive transcriptome signature has been defined ([@bib132]).

Until recently, the study of intra-organ EC heterogeneity has generally been limited to a comparison of large artery, large vein, and microvascular ECs, as these distinctions correspond to the vessel classes that can be physically separated ([@bib20]). This technical limitation is circumvented by scRNA-seq, which provides a broad sampling of the EC population that is independent of vessel size and structure, enabling an unbiased clustering of cell classes based only on gene expression profiles. A recent scRNA-seq study of adult mouse brain vasculature provided the first molecular profile of vascular zonation along the arteriovenous axis ([@bib154]). The data and analyses presented here both corroborate the concept of an EC continuum and extend the findings of Vanlandewijck and colleagues to the early postnatal brain vasculature. In particular, the present work provides strong support for a model in which proliferative ECs are more closely related to venous ECs and tip cells are more closely related to arterial ECs. The data also reveal an unexpected heterogeneity among capillary ECs, with distinct subpopulations that reflect a more venous-like or more arterial-like transcriptional signature. The molecular mechanisms that orchestrate the development of these EC properties remain largely unknown.

A genomic view of canonical Wnt signaling and CNS vascular development {#s3-4}
----------------------------------------------------------------------

The earliest evidence for parenchymal signaling to CNS ECs came from embryonic transplantation experiments in which coelomic cavity ECs acquired BBB characteristics when they invaded pieces of transplanted brain, and brain ECs lost BBB characteristics when they invaded pieces of transplanted mesoderm ([@bib137]; [@bib121]). Subsequent co-culture experiments showed that astrocytes, which send end-foot processes to contact ECs and pericytes, can induce BBB properties in non-CNS ECs and can maintain BBB properties in long-term cultures of CNS-derived ECs ([@bib48]); reviewed in [@bib52]).

At present, canonical Wnt signaling is the only well-characterized cell-cell signaling pathway that promotes BBB formation and maintenance. In the developing and adult CNS, canonical Wnt ligands are secreted by glia (and possibly neurons) and activate receptors on ECs. In mice, EC-specific loss of beta-catenin leads to abortive CNS angiogenesis and loss of BBB integrity and BBB markers; similarly, double knockout of *Wnt7a* and *Wnt7b* in the embryonic CNS inhibits CNS angiogenesis and suppresses the expression of BBB markers ([@bib81]; [@bib135]; [@bib29]; [@bib175]). Nearly identical phenotypes are observed with mutations in the genes coding for GPR124 and RECK, essential receptor cofactors for WNT7A/WNT7B signaling ([@bib69]; [@bib7]; [@bib27]; [@bib174]; [@bib111]; [@bib21]). In the retina, analogous phenotypes are produced by mutations in the genes coding for NORRIN, FRIZZLED4, and TSPAN12 - the ligand, receptor, and co-activator components of a canonical Wnt signaling system that operates in parallel with the WNT7A/WNT7B system ([@bib165]; [@bib61]; [@bib167]; [@bib156]).

The present work extends our understanding of canonical Wnt signaling and BBB development in several ways. First, the location of LEF/TCF motifs in candidate CNS EC-specific CREs permits an initial assessment of which CNS EC genes might be direct targets of canonical Wnt-regulation. Second, the expression of the canonical Wnt reporter exclusively in ECs within and on the surface of the embryonic CNS argues that canonical Wnt signaling does not function as a widely distributed and permissive signal for CNS EC development but may, by virtue of its spatial localization, determine the spatial distribution of the CNS EC fate. The simplest explanation for the observed spatial distribution in canonical Wnt signaling is that it corresponds to the distribution of the relevant ligands: WNT7A, WNT7B, and NORRIN. Third, the nearly identical CNS-specific distribution of ZIC3-expressing ECs - together with (1) the presence of LEF/TCF motifs in candidate CREs near the Zic3 gene, (2) the enrichment of ZIC3 motifs in candidate CNS EC-specific CREs, and (3) the dependence of ZIC3 accumulation on NORRIN/FRIZZLED4 signaling in the developing retinal vasculature ([@bib156]) - strongly suggests that ZIC3 is a downstream effector of the canonical Wnt-controlled EC gene expression program.

In summary, we have dissected from a set of candidate CREs common to many cell types, a subset of candidate CREs that are specific to vascular ECs, and an even smaller subset of candidate CREs that are distinctive for tissue-specific EC subtypes and that are likely to control tissue-specific EC gene expression. The genomic resources and analytical approaches developed here should help in identifying the full network of TFs and TF-binding sites that comprise the downstream effectors of parenchyma-derived signals for EC differentiation and specialization.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\            Designation              Source or reference   Identifiers                                                              Additional information
  (species) or resource                                                                                                                            
  ------------------------ ------------------------ --------------------- ------------------------------------------------------------------------ ------------------------
  Genetic reagent\         Tie2-GFP                 The Jackson\          Stock No: 003658;\                                                       
  (*Mus musculus*; Male)                            Laboratory            RRID:[IMSR_JAX:003658](https://scicrunch.org/resolver/IMSR_JAX:003658)   

  Genetic reagent\         Tie2-Cre                 The Jackson\          Stock No: 008863                                                         
  (*M. musculus*; Male)                             Laboratory                                                                                     

  Genetic reagent\         R26-Tcf/Lef-LSL-\        PMID: 28803732                                                                                 
  (*M. musculus*; Male)    H2B-GFP-6xMYC                                                                                                           

  Antibody                 anti-CD11b\              Biolegends            Cat No: 101235;\                                                         1:1000
                           BV421 (rat monoclonal)                         RRID:[AB_10897942](https://scicrunch.org/resolver/AB_10897942)           

  Antibody                 anti-ICAM2\              BD Biosciences        Cat No: 553326                                                           1:300
                           (rat monoclonal)                                                                                                        

  Antibody                 anti-6xMYC\              PMID: 24411735                                                                                 1:10000
                           (chicken polyclonal)                                                                                                    

  Antibody                 anti-GLUT1\              Thermo Fisher\        RB-9052                                                                  1:500
                           (rabbit polyclonal)      Scientific                                                                                     

  Antibody                 anti-ERG\                Cell Signaling        A7L1G                                                                    1:500
                           (rabbit polyclonal)                                                                                                     

  Antibody                 anti-dopa\               R and D Systems       AF3564                                                                   1:500
                           decarboxylase\                                                                                                          
                           (goat polyclonal)                                                                                                       

  Antibody                 anti-ZIC3\               PMID: 23217714                                                                                 1:50
                           (rabbit polyclonal)                                                                                                     

  Other                    Alexa Fluor\             Thermo Fisher\        L21416                                                                   1:200
                           594-conjugated\          Scientific                                                                                     
                           GS Lectin                                                                                                               

  Peptide,\                Tn5 transposase          Illumina              FC-121--1030                                                             
  recombinant\                                                                                                                                     
  protein                                                                                                                                          

  Commercial\              Worthington\             Worthington\          LK003160                                                                 
  assay or kit             Papain Dissociation\     Biochemical\                                                                                   
                           Kit                      Corporation                                                                                    

  Commercial\              Rneasy Micro\            Qiagen                74034                                                                    
  assay or kit             Plus Kit                                                                                                                

  Commercial\              Dneasy Blood\            Qiagen                69504                                                                    
  assay or kit             and Tissue Kit                                                                                                          

  Commercial\              MinElute\                Qiagen                28604                                                                    
  assay or kit             GelExtraction Kit                                                                                                       

  Commercial\              Agencourt\               Beckman Coulter       A63880                                                                   
  assay or kit             AMPure XP beads                                                                                                         

  Commercial\              EZ DNA\                  Zymo                  D5021                                                                    
  assay or kit             Methylation-Direct\                                                                                                     
                           Kit                                                                                                                     

  Software,\               RSEM                     PMID: 21816040        RRID:[SCR_013027](https://scicrunch.org/resolver/SCR_013027)             
  algorithm                                                                                                                                        

  Software,\               DESeq2                   PMID: 25516281        RRID:[SCR_015687](https://scicrunch.org/resolver/SCR_015687)             
  algorithm                                                                                                                                        

  Software,\               Bowtie2                  PMID: 22388286                                                                                 
  algorithm                                                                                                                                        

  Software,\               MACS2                    PMID: 18798982                                                                                 
  algorithm                                                                                                                                        

  Software,\               DiffBind                 PMID: 22217937        RRID:[SCR_012918](https://scicrunch.org/resolver/SCR_012918)             
  algorithm                                                                                                                                        

  Software,\               deepTools                PMID: 27079975                                                                                 
  algorithm                                                                                                                                        

  Software,\               HOMER                    PMID: 20513432                                                                                 
  algorithm                                                                                                                                        

  Software,\               Monocle                  PMID: 24658644                                                                                 
  algorithm                                                                                                                                        

  Software,\               Methylpy                 PMID: 26030523                                                                                 
  algorithm                                                                                                                                        

  Software,\               BEDTools                 PMID: 20110278        RRID:[SCR_006646](https://scicrunch.org/resolver/SCR_006646)             
  algorithm                                                                                                                                        
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

P7 homozygous *Tie2-GFP* mice ([@bib99]); JAX 003658) were used for isolation of tissue-specific ECs. To visualize Wnt activity in ECs, homozygous *Tie2-Cre* mice ([@bib64]); JAX 008863) were crossed to homozygous *R26-Tcf/Lef-LSL-H2B-GFP-6xMYC* mice ([@bib21]). To control for the possibility of sex-dependent differences, male mice were used for RNA-seq, ATAC-seq, and MethylC-seq. All mice were housed and handled according to the approved Institutional Animal Care and Use Committee (IACUC) protocol MO16M367 of the Johns Hopkins Medical Institutions.

EC isolation {#s4-2}
------------

ECs were isolated as previously described with some modifications ([@bib30]; [@bib170]). Reagents used included the Worthington Papain Dissociation System (LK003160, Worthington Biochemical Corporation, Lakewood, NJ), Dulbecco's PBS (DPBS, 14287072, Thermo Fisher Scientific, Waltham, MA), trehalose (T0167-10G, MilliporeSigma, Burlington, MA), bovine serum albumin (A7906, Sigma-Aldrich, Burlington, MA), 20 um cell strainers (CellTrics, Sysmex Partec, Gorlitz, Germany), and anti-CD11b BV421 (101235, Biolegends, San Diego, CA). For liver, lung, and kidney, a single P7 *Tie2-GFP* mouse typically yielded enough tissue for FACS sorting. For P7, two mice were used. Mice were euthanized and tissues of interest were rapidly placed into Dulbecco's PBS (DPBS), minced using a razor blade, and enzymatically dissociated in 2.5 ml of papain solution (20 units papain per ml; 1 mM L-cysteine; 0.5 mM EDTA; 5% trehalose; 100 units of DNase per ml) for 1 hr at 37° Celsius. Following this incubation, ovomucoid inhibitor/BSA solution reconstituted at 10 mg per ml was added at 1:10 dilution. The dissociated tissue was gently triturated to form a single-cell suspension. This suspension was then layered on top of a solution consisting of 5 mg per ml ovomucoid inhibitor/BSA and 5% trehalose and centrifuged at 70 x g for 5 min at room temperature. The cell pellet was resuspended in 0.02% BSA and 5% trehalose solution (FACS buffer) and subsequently filtered through a 20 um mesh filter. After another round of centrifugation at 300 x g for 5 min, the cells were resuspended in FACS buffer. Cells were incubated with anti-CD11b BV421 (a macrophage marker) at 1:1000 dilution for 30 min at room temperature. Following antibody staining, cells were pelleted at 300 x g and washed twice with 1 ml of FACS buffer.

Cells were sorted using a MoFlo XDP Sorter (Beckman Coulter, Brea, CA). Viable ECs were defined as GFP positive, propidium iodide negative, and CD11b BV421 negative. For RNA-seq, viable ECs (GFP-positive) and viable parenchymal cells (GFP-negative) were sorted directly into QIAGEN Buffer RLT Plus. For single-cell RNA-seq, ATAC-seq, and MethylC-seq, viable ECs were sorted into FACS buffer for downstream sample preparation.

Immunohistochemistry {#s4-3}
--------------------

E13.5 embryos were immersion fixed in 4% paraformaldehyde (PFA) overnight at 4° Celsius. For P7 brain, liver, lung, and kidneys, mice were deeply anesthetized and then the tissues were fixed by intracardiac perfusion with PBS followed by 4% PFA in PBS. Tissues were further fixed by immersion in 4% PFA in PBS overnight at 4°C. Embryos and tissues were embedded in 3% low-melting point agarose and vibratome sectioned at a thickness of 120 um. The following reagents were used: DAPI, rat anti-ICAM2 (1:300; 553326, BD BioSciences, San Jose, CA), chicken anti-6xMYC (1:10,000; [@bib162]), rabbit anti-GLUT1 (1:500; RB-9052, Thermo Fisher Scientific), rabbit anti-ERG (1:500; A7L1G, Cell Signaling Technology, Danvers, MA), goat anti-dopa decarboxylase (1:500; AF3564, R and D Systems, Minneapolis, MN), Alexa Fluor 594-conjugated GS Lectin (1:200; L21416; Thermo Fisher Scientific), rabbit anti-ZIC3 (1:50; [@bib156]). For the images in [Figure 6A and C](#fig6){ref-type="fig"}, the unit for quantification was a rectangle 410 um high x 355 um wide, and quantifications were performed using three adjacent rectangles overlying the CNS and three adjacent rectangles overlying the mesoderm (i.e. non-CNS) region. Within each rectangle, the number of MYC+, ERG+, or ZIC3 +nuclei were counted and the vasculature was traced in Adobe Illustrator and the lengths of the traced lines were quantified by using ImageJ to count the resulting pixels.

Whole mount retina in situ hybridization {#s4-4}
----------------------------------------

Flat-mount retina ISH was performed as previously described ([@bib117]). Briefly, enucleated eyes were fixed in 2% PFA for 5 min at room temperature and then transferred to hypertonic PBS (2x PBS) for 5 min at room temperature. Retinas were dissected and four radial incisions were made. With the vitreal surface facing up, buffer was slowly removed until retinas were flat. In order to fix the flattened retinas, methanol cooled to −20°C was added dropwise. For ISH, fixed retinas were first transferred to 4% PFA for 5 min at room temperature, then washed three times with RNAase-free PBS with 0.1% Tween-20 (PBST), digested with 20 ug/mL Proteinase K (P2308, Sigma-Aldrich) for 15 min at room temperature, fixed in 0.2% glutaraldehyde with 4% PFA, washed three times with PBST, and finally transferred to hybridization solution (50% formamide, 5x saline-sodium citrate buffer, 5 mM EDTA, 2% Blocking Reagent (11096176001, Sigma-Aldrich), 50 ug/mL yeast RNA, 100 ug/mL heparin, 0.5% CHAPS, and 0.1% Triton X-100) at 65°C. After 2 hr of prehybridization, digoxigenin-labeled riboprobes were added, and hybridization proceeded overnight at 65°C. After a series of washes ([@bib117]), retinas were blocked for 2 hr at room temperature in maleic acid buffer with 0.1% Tween-20 (MABT), 2% Blocking Reagent, and 10% normal goat serum. Then, retinas were incubated with anti-digoxigenin-AP Fab fragments (1:1000; 11093274910, Sigma-Aldrich) overnight at 4°C. The following day, retinas were washed four times for 1 hr each at room temperature and then overnight at 4°C in MABT. Retinas were washed three times in AP buffer with 0.1% Tween-20 for 5 min at room temperature, and then they were stained for 1--4 hr with AP buffer and nitro-blue tetrozolium (NBT; 350 ug/mL) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP; 175 ug/mL). After staining, retinas were washed twice with PBST, post-fixed for 5 min with 4% PFA, washed twice with PBST, and stained with Alexa Fluor 594-conjugated GS Lectin (1:100) overnight at 4°C. For imaging, retinas were dehydrated by transferring the retinas between increasing concentrations of ethanol (25% in PBST, 50% in PBST, 75% in PBST, and 100%). Finally, retinas were cleared in benzyl benzoate:benzyl alcohol (2:1). For presentation, the purple ISH signal was converted to green, and the GS Lectin signal was converted to magenta.

Microscopy {#s4-5}
----------

Confocal images were captured with an LSM700 (Zeiss, Jena, Germany) microscope. ISH images were captured with a Zeiss Imager Z1 Microscope using Zeiss AxioVision 4.6 software. Image processing was performed using FIJI ([@bib126]).

RNA and DNA sample preparation {#s4-6}
------------------------------

RNA was extracted from an aliquot of dissociated tissue prior to filtering and antibody staining and from GFP-positive and GFP-negative FACS sorted cells using the RNeasy Micro Plus kit (74034, QIAGEN, Venlo, Netherlands). DNA for MethylC-seq was prepared from GFP-positive FACS-sorted cells using the DNeasy Blood and Tissue kit (69504, QIAGEN). For ATAC-seq,\~50,000 GFP-positive FACS-sorted cells were resuspended in ice-cold lysis buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl~2~, 20 mM Tricine-KOH, 0.1% Igepal CA-630) and immediately centrifuged at 500 x g for 10 min at 4°C to prepare nuclei. The resulting nuclear pellet was resuspended in a 50 ul reaction volume in Tn5 transposase and transposase reaction buffer (FC-121--1030, Illumina Inc., San Diego, CA) and the tagmentation reaction was incubated at 37°C for 30 min.

Library preparation and sequencing {#s4-7}
----------------------------------

Each RNA-seq, ATAC-seq, and MethylC-seq analysis was conducted on two biological replicates except for brain EC ATAC-seq, which was conducted on three biological replicates. Single-cell RNA-seq was conducted with a single sample. Libraries for RNA-seq and ATAC-seq were prepared as previously described, with minor modifications ([@bib12]; [@bib82]; [@bib98]; [@bib97]). For RNA-seq, total RNA was converted to cDNA and amplified (Ovation Ultralow System V2-32, 0342HV, NuGEN Technologies, San Carlos, CA). Amplified cDNA was fragmented, end-repaired, linker-adapted, and single-end sequenced for 75 cycles on a NextSeq500 (Illumina Inc.). Tagmented DNA was purified using QIAGEN MinElute GelExtraction kit (28604, Qiagen). ATAC-seq libraries were PCR amplified for 11 cycles. Agencourt AMPure XP beads (A63880, Beckman Coulter) were used to purify ATAC-seq libraries, which were then paired-end sequenced for 36 cycles on a NextSeq500. MethylC-seq library preparation discussed below.

Data analysis {#s4-8}
-------------

Most data analysis was performed as previously described ([@bib97]). For basic data processing, exploration, and visualization, we used deepTools ([@bib116]), BEDTools ([@bib115]), RStudio ([@bib145]), the tidyverse collection of R packages ([@bib161]), ggplot2 ([@bib160]), pheatmap ([@bib66]), and custom scripts. Reads were aligned to the mm10 genome using Bowtie2 ([@bib73]). The Integrative Genomics Viewer (IGV) was used to visualize bigwig files generated by deepTools bamcoverage ([@bib123]; [@bib149]).

RNA-seq {#s4-9}
-------

Three different sets of RNA-seq data were generated from papain dissociated P7 *Tie2-GFP* brain, liver, lung, and kidney: (1) total tissue; (2) GFP-negative FACS-sorted cells; and (3) GFP-positive FACS-sorted cells. RSEM version 1.3.0 ([@bib78]) was used to align reads with Bowtie2 to the mm10/GRCm38 genome and calculate transcript expression using Ensembl annotation (*rsem-calculate-expression* \--bowtie2 \--estimate-rspd \--append-names \--output-genome-bam \--sort-bam-by-coordinate). Differentially expressed genes were identified using EBSeq version 1.18.0 ([@bib76]). To filter out background transcripts from surrounding parenchymal cells, we determined a set of EC-enriched transcripts for each tissue by comparing GFP-positive and GFP-negative sorted cells. A transcript was considered EC-enriched if it met the following three criteria: (1) a minimum two-fold enrichment in GFP-positive compared to GFP-negative samples; (2) a posterior probability of differential expression (PPDE) greater than or equal to 0.95 \[PPDE = (1 - false discovery rate)\]; (3) relative expression greater than or equal to 10 transcripts per million (TPM) in both biological replicates. A gene was considered to be differentially expressed between EC subtypes if it met the following criteria: (1) EC-enriched with minimum of two-fold enrichment between one subtype and all three other subtypes; (2) a PPDE greater than or equal to 0.95; (3) a TPM value greater than or equal to 10 in both biological replicates. Principal component analysis was performed on 'regularized log'-transformed data using the DESeq2 *rlog* and *plotPCA* function ([@bib87]). Gene ontology enrichment analysis was performed on EC tissue-specific genes using the online enrichment analysis tool ([@bib96]) from the Gene Ontology Consortium.

ATAC-seq {#s4-10}
--------

We aligned ATAC-seq data using Bowtie2 (Version 2.3.2 t -X 2000 \--no-mixed \--no-discordant) and then removed duplicate reads (*picard MarkDuplicates*). Peaks were called using MACS2 (Version 2.1.1.20160309 *callpeak* \--nomodel \--keep-dup all \--shift −100 \--extsize 200 \--call-summits) ([@bib171]). Peaks were then filtered for fold-change \>2 and -log(qvalue)\>2. ATAC-seq peaks visualized on the browser were called using all fragment sizes. To determine the fraction of mapped reads in called peaks, we used deepTools *multiBamSummary* (BED-file \--outRawCounts \--samFlagInclude 64). Samtools *view* (-s) was used to subsample reads. For all downstream analyses, ATAC-seq peaks were called using paired-end sequencing fragments \< 100 bp in length, which are enriched for nucleosome-free regions.

To identify differential ATAC-seq peaks between ECs isolated from brain, liver, lung, and kidney, we used DiffBind ([@bib134]; [@bib125]) with both DESEQ2 and EdgeR ([@bib124]; [@bib91]) methods. DiffBind was used to develop a set of consensus peaks between replicates using the requirement that peaks must be in at least two thirds of the replicates (minOverlap = 0.66). From this new set of peaks, a consensus peakset was generated corresponding to the discrete set of peaks identified between all samples being compared (minOverlap = 1). Log~2~ transformed normalized read counts in each sample are then tabulated over each peak region and plotted. To retrieve a set of high-confidence, cell type-enriched peaks, differential peak analysis was carried out using DESEQ2 and EdgeR. From both sets of analysis, we filtered for peaks with an absolute fold difference \>2 and FDR \< 0.05. In R, the union of these two sets of peaks was used to generate a final set of differentially enriched peaks for each sample. Principal component analysis was performed on 'regularized log'-transformed data using the DESeq2 *rlog* and *plotPCA* function.

Methylome sequencing {#s4-11}
--------------------

DNA methylome libraries were prepared using a modified snmC-seq protocol adapted for bulk DNA samples ([@bib88]). 20 ng of purified genomic DNA with 0.5% unmethylated lambda DNA spike-in (D1521, Promega) was bisulfite converted using the EZ DNA Methylation-Direct Kit (D5021, Zymo) following the product manual and was eluted in 10 µl M-Elution buffer. 9 µl converted DNA was mixed with 1 µl P5L_random oligo (5 µM,/5SpC3/TTCCCTACACGACGCTCTTCCGATCTNNNNNNNNN, IDT) followed by heat denaturing at 95°C for 3 min using a thermocycler. The samples were chilled on ice for 2 min and mixed with 10 µl enzyme mix containing 2 µl of Blue Buffer (B0110, Enzymatics), 1 µl of 10 mM dNTP (N0447L, NEB), 1 µl of Klenow exo- (50 U/µl, P7010-HC-L, Enzymatics) and 6 µl H2O. The samples were incubated using a thermocycler with the following program: 4°C for 5 min, ramp up to 25°C at 0.1°C/s, 25°C for 5 min, ramp up to 37°C at 0.1°C/s, 37°C for 60 min, 4°C. A 3 µl enzyme mix containing 2 µl of Exonuclease 1 (20U/µl, X8010L, Enzymatics) and 1 µl of Shrimp Alkaline Phosphatase (rSAP, M0371L, NEB) was added to the samples. The samples were incubated at 37°C for 30 min using a thermocycler. Samples were cleaned-up using 0.8x SPRI beads and eluted with 10 µl M-Elution buffer. Eluted samples were heated at 95°C for 3 min using a thermocycler and were chilled on ice for 2 min. Samples were mixed with 10.5 µl Adaptase master mix containing 2 µl Buffer G1, 2 µl Regent G2, 1.25 µl Reagent G3, 0.5 µl Enzyme G4, 0.5 µl Enzyme G5 and 4.25 µl M-Elution buffer (Accel-NGS Adaptase Module for Single Cell Methyl-Seq Library Preparation, 33096, Swift Biosciences). Samples were incubated at 37°C for 30 min, 95°C for 2 min and 4°C using a thermocycler. 1 µl 30 µM P5 indexing primer and 5 µl 10 µM P7 indexing primer and 25 µl KAPA HiFi HotStart ReadyMix, (KK2602, KAPA BIOSYSTEMS) were added into each sample followed by thermocycling using the following program - 95°C for 2 min, 98°C for 30 s, 10 cycles of (98°C for 15 s, 64°C for 30 s, 72°C for 2 min), 72°C for 5 min and then 4°C. PCR products were cleaned up using 0.8x SPRI beads twice. Methylome libraries were sequenced using an Illumina HiSeq 4000 instrument with 5% PhiX DNA spike-in.

Adaptor sequences were trimmed from sequencing reads using Cutadapt 1.11 with parameters -f fastq -q 20 m 50 -a AGATCGGAAGAGCACACGTCTGAAC -A AGATCGGAAGAGCGTCGTGTAGGGA. We further trimmed 10 bp from both 5'- and 3'- ends of both R1 and R2 reads with parameters -f fastq -u 10 u −10 m 30. Trimmed R1 and R2 reads were mapped to the mm10 reference genome as single-end reads using bismark 0.14.4 with parameter \--bowtie2. \--pbat option was used for mapping R1 reads. Mapped reads were sorted using Samtools 1.3 followed by removing duplicate reads using Picard 1.141 MarkDuplicates with parameter REMOVE_DUPLICATES = true. Reads were further filtered by MAPQ \> 20 using samtools view with parameter -bhq20. Methylation level at each cytosine was summarized using call_methylated_sites from Methylpy package (<https://github.com/yupenghe/methylpy/>).

Methylome analysis and identification of ECTS-hypo-DMRs, UMRs, LMRs, and large hypomethylation features {#s4-12}
-------------------------------------------------------------------------------------------------------

DMRs were identified as previously described in ([@bib98]) using *DMRfind* from the Methylpy package with parameters num_sims = 3000, num_sig_tests = 100, use_mc_status = False, dmr_max_dist = 250, sig_cutoff = 0.01. DMRs showing hypo-methylation in both biological replicates were used for further analyses.

UMRs and LMRs were identified using MethylSeekR ([@bib13]) with m (methylation level)=0.3% and 5% FDR. DMVs were identified as UMRs \> 3 kb. To identify large ECTS-hypo-DMRs, all ECTS hypo-DMRs with inter-DMR distances \< 1 kb were merged (bedtools merge -d 1000). Large ECTS-hypo-DMRs were defined as merged ECTS-hypo-DMRs\>2 kb.

For MethylC-seq scatterplots in [Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, *multiBigwigSummary* (BED-file \--outRawCounts) of deepTools was used to compute the mean fraction of mCG in a 5 kb window 3' of the TSS of protein-coding genes. Gene ontology analysis of shared DMVs was performed using Genomic Regions Enrichment of Annotations Tool (GREAT) ([@bib93]). To compare the degree of methylation between EC subtypes at DMVs overlapping differentially expressed TF genes, we applied the following steps: (1) within each EC subtype, all DMVs in a 20 kb window 5' to the TSS of the gene of interest were joined into a single contiguous block, (2) overlapping DMVs between EC subtypes were merged to generate a genomic interval that spanned the greatest extent of all the DMVs, (3) within the merged interval, the fraction mCG methylation was calculated for each EC subtype. Computation was performed using *multiBigwigSummary.* In [Figure 4---figure supplement 3B and C](#fig4s3){ref-type="fig"}, *computeMatrix (*reference-point \--referencePoint center) was used to compute either the degree of methylation at ATAC-seq peaks or the ATAC-seq signal at UMRs, LMRs, and DMRs as a function of distance from the center of regions. Then the deepTools function *plotProfile* was used to generate output data in table form for plotting in R. The ATAC-seq signal at hypomethylated features was upper quartile normalized using the *uqua* function of the R package NOISeq ([@bib144]; [@bib143]). For [Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}, each line was translated vertically so that the value at position −1500 bp is 0.

Feature overlap analysis {#s4-13}
------------------------

*Bedtools intersect* (-u) was used to determine features that overlapped with other features by greater than or equal to 1 bp. *Bedtools window* (-w 100000) was used to identify CREs within 100 kb of ECTSGs. For [Figure 2B](#fig2){ref-type="fig"}, statistically significant enrichment was tested by hypergeometric distribution using MATLAB *hygecdf* function as previously described in [@bib98]. For [Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}, statistically significant enrichment was tested with *hygecdf(number of category i feature overlapping with category j DEG, sample size of either all hypo-DMRs and ECTS-hypo-DMRs or all differential APs and ECTSAPs, number of features (either DMRs or APs) that overlap with category j DEG, sample size of category i feature, 'upper')*.

Transcription factor DNA binding motif enrichment analysis {#s4-14}
----------------------------------------------------------

TF binding motifs in candidate regulatory regions (ECTSAPs and ECTS-hypo-DMRs) were identified and analyzed using the HOMER suite of tools for motif discovery ([@bib49]), in particular, *findMotifsGenome.pl* (-size given). HOMER searches for enriched motifs using a de novo strategy of looking for enriched k-mers in target regions compared to a set of random background genomic regions. HOMER also maintains a custom database of known motifs based on published ChIP-Seq data sets. From the set of known motifs, we filtered for motifs exhibiting a q-value \<0.001 and a fold enrichment (defined as the % of target regions with the motif divided by the % of background regions with the motif) \>2 for each sample. These were considered to be statistically significant. De novo-enriched motifs could typically be matched to a motif from the list of enriched known motifs. Because many members of a TF family share a similar core motif, we chose one representative member of each TF family motif to display in motif heatmaps ([Figures 5B and F](#fig5){ref-type="fig"}). *AnnotatePeaks.pl* (-m -size 1000 -hist 5) was used to generate histograms of enriched motifs, and *annotatePeaks.pl* (-center -size given -multi) was used to center candidate regions on instances of motifs. To identify the number of features containing a given motif, we used *annotatePeaks.pl* (-m -nomotifs -noann -nogene). To determine statistically significant enrichment of a motif (as in [Figure 5---figure supplement 1B,C and E](#fig5s1){ref-type="fig"}), we used *hygecdf(number of category i feature overlapping with category j motif, sample size of either ECTS-hypo-DMRs or ECTSAPs within 100 kb of ECTSGs, number of features (either DMRs or APs) that contain category j motif, sample size of category i feature, 'upper').*

Droplet-based single-cell RNA-seq of brain ECs {#s4-15}
----------------------------------------------

FACS purified GFP-postive P7 brain ECs from a *Tie2-GFP* mouse were processed through the GemCode Single Cell Platform using the GemCode Gel Bead, Chip, and Library Kits (10X Genomics, Pleasanton, CA) as per the manufacturer's protocol. In brief, papain-dissociated ECs were sorted into 0.4% BSA--DPBS, and approximately 10,000 FACS-purified singlet brain ECs were added to the channel with a final recovery rate of 4,257 cells. ECs were then partitioned into gel beads in emulsion in the GemCode instrument for cell lysis and barcoded oligo-DT priming and reverse transcription of poly-adenylated RNA. This was followed by PCR amplification, shearing, and 5′ adaptor and sample index attachment. Libraries were sequenced on an Illumina HiSeq 2500.

Analyses of single EC transcriptomes {#s4-16}
------------------------------------

scRNA-seq data were pre-processed using the cellranger pipeline (v2.0; 10x Genomics) with default settings. The normalized geneXcell matrix was used as input for the Monocle R/Bioconductor package ([@bib152]). Log-normalized expression estimates (with a pseudocount of 1) were used as input for a modified dpFeature analysis (Monocle). Briefly, high-dispersion genes were identified as those genes with a residual greater than 1 \* the estimated mean-variance split using the \`estimateDispersions\` method in Monocle. Non-endothelial-specific transcripts in the high-dispersion gene set, defined as transcripts enriched \>2 fold by bulk RNA-seq in the FACS-purified GFP-negative fraction compared to the GFP-positive fraction, likely derived from high-abundance transcripts released and solubilized by lysis of non-ECs during the preparation of the single-cell suspension. 311 non-EC specific genes were excluded from the high-dispersion gene set and removed from subsequent analyses. For preliminary cell clustering, principal component analysis (PCA) was performed on the high-variance genes and components 2--10 were visualized in two dimensions using t-Distributed Stochastic Neighbor Embedding (t-SNE) ([@bib153]; [@bib68]; [@bib89]). Component one was excluded as it was determined to primarily reflect capture efficiency (num_genes_expressed). Initial clusters were identified from the 2D embedding using Mclust. To refine the list of genes contributing to the initial clustering, we performed a Monocle differential gene test with respect to cluster assignment, accounting for total mRNAs in both full and reduced models as well. The top 1200 genes with significant differential expression across clusters were then selected and used as input for a second PCA and components 2--8 were reduced into two dimensions using tSNE. Final cluster assignments were determined using Mclust on the updated 2D embedding. Clusters were annotated based on the expression of canonical EC subtype markers and a differential gene test between the subtypes was performed using the R package Monocle. The final six EC clusters conformed well to the expression patterns of known markers for arterial, venous, tip, capillary and mitotic cells. Cell trajectory analyses were carried out in Monocle on the same 1200 differentially expressed genes used for the second PCA.
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###### Gene expression data.

(A-C) Transcript abundances in raw expected read counts (A), cross-sample normalized read counts (B), and TPMs (C). (D) List of EC-enriched transcripts. (E) List of all differentially expressed genes between one or more pairs of EC subtypes. (F) List of ECTSGs
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###### Gene ontology (GO) enrichment analysis

\(A\) GO enrichment analysis of brain ECTSGs. (B) GO enrichment analysis of liver ECTSGs. (C) GO enrichment analysis of lung ECTSGs. (D) GO enrichment analysis of kidney ECTSGs.
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###### Hypomethylated features in each EC subtype

(A-D) UMRs for each EC subtype. (E-H) LMRs for each EC subtype. (I-L) DMRs for each EC subtype. (I'-L') ECTS-hypo-DMRs for each EC subtype. (M-P) DMVs for each EC subtype. (Q-T) ECTS-large hypo-DMRs for each EC subtype. (U) LMRs found only in ECs relative to photoreceptors and cortical neurons. (V) LMRs from (U) that are shared between EC subtypes
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###### Numbers underlying heatmaps shown throughout figures.
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###### Accessible chromatin peaks in each EC subtype.

(A-D) ATAC-seq peaks for each EC subtype called using the full range of ATAC-seq fragment lengths. (E-H) ATAC-seq peaks for each EC subtype called using \<100 nt ATAC-seq fragments. (I-L) Differential ATAC-seq peaks (\<100 nt) for each EC subtype. (I'-L') ECTSAPs (\<100 nt) for each EC subtype. (M) ATAC-seq peaks (\<100 nt) found only in ECs relative to photoreceptors and cortical neurons. (N) ATAC-seq peaks from (M) that are shared between EC subtypes.
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###### HOMER motif files used in this study.

\(A\) HOMER motif files for enriched k-mers identified in ECTS-hypo-DMRs and ECTSAPs. (B) HOMER motif file used for representative member of TF families. (C) HOMER motif file used for paired ETS:ZIC motif.
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###### Top 25 genes for each single-cell RNA-seq cluster.

\(A\) Arterial cluster markers. (B) Capillary-A cluster markers. (C) Capillary-V cluster markers. (D) Mitotic cluster markers. (E) Tip cell cluster markers. (F) Venous cluster markers.
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Sequencing data have been deposited in GEO under accession code GSE111839

The following dataset was generated:

Sabbagh MFHeng JSLuo CCastanon RGNery JRRattner AGoff LAEcker JRNathans J2018Transcriptional and Epigenomic Landscapes of CNS and non-CNS Vascular Endothelial Cells<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111839>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE111839).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Elisabetta Dejana as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Didier Stainier as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Thanks for submitting your manuscript to *eLife*. The two reviewers and I found the paper of interest and certainly important for the advancement of the field.

However, as specified in detail in their comments the reviewers feel that the manuscript requires revision. In particular, the data on in vitro brain endothelial cell culture should be done in a more accurate way. For instance, the role of canonical Wnt in maintenance of the BBB characteristics in vitro should be analyzed in more detail as recommended. Both reviewers 2 and 3 ask for other relevant additions for a more adequate comparison of cultured and freshly isolated endothelial cells. Some relevant references are missing:

Vanlandewicjk et al., 2018; Paolinelli et al., 2013 for in vitro BBB cell culture.

Importantly, Vanlandewicjk et al., should be cited and discussed.

The full reviews are also included for your reference, as they contain detailed and useful suggestions.

Reviewer \#1:

This is a particularly complex paper that focus on endothelial heterogeneity in different organs (liver, lung kidney and brain).

The authors made an extensive effort and report interesting data on the transcriptome, accessible chromatin and methylome of the different types of ECs. They identified both shared and organ specific signaling pathways that regulate endothelial specificity.

I believe that the paper contains a lot of important information that was only discussed and hypothesized before but not directly shown such as the correlation between venous markers and cell proliferation or arterial markers and tip cells. Therefore, this paper will certainly add to our knowledge on endothelial cells heterogeneity and plasticity. The text and experiments are particularly detailed and not always easy to digest but it is probably impossible to synthetize so many different and extensive data in a more simple way.

Overall, I am in favor of the publication of this work without any specific change or revision.

Reviewer \#2:

This manuscript entitled \"Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells\" analyzes transcriptional and epigenomic differences between four distinct types of ECs (brain, lung, liver and kidney) using RNA-seq, DNA methylation profiles and accessible chromatin regions with ATAC sequencing. In addition, the authors isolate brain ECs from P7 brains and culture them for a week to identify potential changes in RNA-seq, DNA methylome and accessible chromatin between brain ECs in vivo and in vitro that may account for loss of BBB properties in vitro.

Although, multiple studies have now been performed on identification of transcriptional differences between ECs in different organs (brain, lung, liver) and the concept that the vasculature is highly specialized for each organ is well accepted in the field of vascular biology, the study provides some novel and interesting insights into the biology of transcriptional specializations of ECs for distinct organs. This is a tour-de-force study that provides a detailed analysis of differences in DNA methylome and accessible chromatin between distinct cell types.

The study suffers from some drawbacks that need to be addressed in greater detail to enhance the significance of the study.

1\) One of the major analyses is the comparison between brain ECs in vivo and in vitro. The authors show nicely that several genes that are activated by canonical Wnt signaling become downregulated within a week in culture. What specific culture conditions were used to culture mouse endothelial cells? Several key studies in the field of vascular biology have shown that addition of serum or ECGS in the media can affect the transcriptional landscape of ECs in culture. Therefore, the findings from the authors about the presence of differences are not surprising. However, can the authors perform a similar analysis using more defined conditions and various EC media to determine which conditions may provide the minimum divergence from the brain ECs? This will be highly valuable for vascular biologists and represent a major advancement in the field.

2\) Does addition of Wnts or Wnt agonists to cultured brain ECs restores their properties to a certain extent or is the divergence in culture so extensive that is irreversible? When does this process become irreversible?

3\) Several studies have shown that brain or lung ECs in culture retain some tissue-specific identity and expression of certain genes in culture. What happens to some of the BBB-specific genes in cultured brain ECs? The authors do not show in detail BBB specific genes.

4\) Do lung ECs diverge to a \"generic\" EC when cultured for several days? It will be important to test this hypothesis and show the data for another cell type beside the CNS.

5\) In Figure 7, the authors show some specific new markers for tip cells or capillary-A, capillary-V markers. A recent study by Betsholtz has shown that there is a zonal expression of several endothelial genes. Therefore, these findings are not surprising. Have the authors validated any of these markers in particular tip cell markers? They only show DCC. It will be important to validate other genes.

The data file provided so far are sufficient.

Reviewer \#3:

Sabbagh et al., compare the transcriptional and epigenetic landscapes of endothelial cells in different organs: brain, liver, lung, and kidney. This is the first study to perform both RNA-seq, MethylC-seq and ATAC-seq of ECs in different organs, and the study also includes some brain EC vascular zonation analyses (a novel and timely topic). Lastly, the study compares expression of freshly isolated ECs and in vitro ECs cultured 8 days, but flaws exist with the design of this final experiment (see below comments). While the present study is interesting and has some novelty overall, the study could be improved by addressing the comments below:

1\) In vivo and in vitro transcriptional and epigenetic data (Figure 9 and Figure 10) are generated from two different strains of mice at two different developmental ages (in vivo: *Tie2-GFP* mice at P7; in vitro: C57BL/6 mice at P28-56); then the authors conclude from this data that in vitro culture affects gene expression. For this comparison to be valid, the authors should similarly analyze in vivo and in vitro cultured cells from the same genetic mouse strain at the same age, and then determine the degree to which in vitro culture shifts gene expression. The time in culture is also important as it might affect the results. For instance, after how many population doubling times EC were studied? With increased timing in culture ECs might turn towards senescent-like phenotype. It would be really cool to show for how long they can sustain close to their in vivo determine profile. This is also why comparing mice at similar age may be important especially as a recent study in Nature 2018 suggests that some endothelial cells do not fit the A-V zonation pattern and exhibit high expression of ribosomal protein transcripts, which indicates that protein synthesis occurs throughout the A-V axis.

2\) The entire study uses 2 biological replicates consisting of 2 total number of mice for liver, kidney and lung and 4 total mice (2 mice pooled per replicate) for brain transcriptional and epigenetic data (except brain ATAC-seq that was conducted with 3 biological replicates). We think that 2 biological replicates may not be sufficient.

3\) The authors may consider developing a website to enable readers to more easily access the study\'s transcriptional and epigenetic data, as many other groups have done (see for example Zhang et al., 2014; He et al., 2016; Vanlandewijck et al., 2018).

4\) The manuscript\'s overall interpretation, readability and data presentation could be improved. For example, the authors present the degree of methylation of differentially expressed EC genes in each organ expressed as gene browser snapshot and bar/scatter plots (Figure 2---figure supplement 2), but no statistical analyses are performed, and the methylation pattern interpretation is not always clear. Moreover, the many gene browser snapshots presented throughout the figures are not reader friendly and do not clearly demonstrate the point the authors are trying to make in the text.

5\) In addition to reporting Gene Ontology (GO) pathways shared by brain, liver, lung and kidney (Figure 2---figure supplement 1E), the authors should also include GO pathways terms that are unique to ECs in each organ.

6\) The authors present heatmaps depicting gene expression and mean fraction of methylated CG in the gene body for genes within four HOX clusters presented anterior to posterior (Figure 3C). Many of the genes shown lack an association between high gene expression and high methylation or low gene expression and low methylation. What is the interpretation of this figure? This should be added and adequately discussed in the text.

7\) It is quite surprising the authors do not cite a recent Nature paper that is the first to present transcriptional analysis of vascular zonation profiles of brain endothelial cells and mural cells (Vanlandewicjk et al., Nature, 2018). This paper should be cited and discussed. In regard to this paper and clustering of different brain endothelial types along the A-V axis -- arterial, capillary and venous (also shown in the authors Figure 7 and Figure 8), do the authors know which endothelial cell clusters are represented by their in vitro analysis? This also could be the source for variation between in vitro and in vivo findings, as in vitro ECs might have differentially enriched clusters of cells compared to in vivo, depending on the source of origin.

8\) The EC Methyl-seq correlation between different organs is very good: r=0.95-0.97 (Figure 2A; Figure 2---figure supplement 1B) and r=0.90-0.92 (Figure 4---figure supplement 3), compared to the EC RNA-seq (normalized counts) correlation between different organs (r=0.45-0.61) (Figure 1B). Why is this? The authors may want to elaborate on this in the discussion.

9\) It would be helpful if the authors can provide quantification for their immunohistochemistry data (e.g., Figure 6).

10\) This study only uses male mice. This is a limitation given the NIH\'s urge to be inclusive of both genders.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Didier Stainier (Senior Editor), a Reviewing Editor, and two reviewers.

All of the reviewers agree that the paper has been improved significantly after revision. However, some doubts still remain that need to be addressed before acceptance. These are related to the comparison of brain derived endothelial cells in vivo or in culture conditions in vitro.

Specifically, a more accurate study on the culture conditions used seems important to draw conclusions. It has been known for many years that when brain endothelial cells are isolated and cultured they lose their BBB properties quite rapidly, unless they are maintained in co-culture with astrocytes (see, for instance, papers from Cecchelli et al., and many others) or when Wnt is added to the medium. In addition, the extreme functional variability of endothelial cells derived from different vascular regions of the brain may further confuse the final results. For instance, when the cells have an arterial, venous or capillary origin or when they derive from vessels of different brain regions.

The shared view of the reviewers is that, if the authors agree to drop these data (subsection "Rapid loss of the CNS EC transcriptional signature upon culturing of primary brain ECs" and Subsection "Changes in accessible chromatin in primary brain EC culture reflect loss of Wnt signaling" and related results), the paper would be more focused and solid and, overall, will add a lot to our understanding about the diversification of endothelial cells to distinct organ-specific identities.

We hope that the authors accept to drop this part of the results so that the paper will be acceptable for publication in *eLife*. This conclusion was reached after lively and motivated discussion among the reviewers and the Editors.

10.7554/eLife.36187.042

Author response

> Thanks for submitting your manuscript to eLife. The two reviewers and I found the paper of interest and certainly important for the advancement of the field.
>
> However, as specified in detail in their comments the reviewers feel that the manuscript requires revision. In particular, the data on in vitro brain endothelial cell culture should be done in a more accurate way. For instance, the role of canonical Wnt in maintenance of the BBB characteristics in vitro should be analyzed in more detail as recommended. Both reviewers 2 and 3 ask for other relevant additions for a more adequate comparison of cultured and freshly isolated endothelial cells. Some relevant references are missing:
>
> Vanlandewicjk et al., 2018; Paolinelli et al., 2013 for in vitro BBB cell culture.
>
> Importantly, Vanlandewicjk et al., should be cited and discussed.
>
> The full reviews are also included for your reference, as they contain detailed and useful suggestions.
>
> Reviewer \#2:
>
> This manuscript entitled \"Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells\" analyzes transcriptional and epigenomic differences between four distinct types of ECs (brain, lung, liver and kidney) using RNA-seq, DNA methylation profiles and accessible chromatin regions with ATAC sequencing. In addition, the authors isolate brain ECs from P7 brains and culture them for a week to identify potential changes in RNA-seq, DNA methylome and accessible chromatin between brain ECs in vivo and in vitro that may account for loss of BBB properties in vitro.
>
> Although, multiple studies have now been performed on identification of transcriptional differences between ECs in different organs (brain, lung, liver) and the concept that the vasculature is highly specialized for each organ is well accepted in the field of vascular biology, the study provides some novel and interesting insights into the biology of transcriptional specializations of ECs for distinct organs. This is a tour-de-force study that provides a detailed analysis of differences in DNA methylome and accessible chromatin between distinct cell types.
>
> The study suffers from some drawbacks that need to be addressed in greater detail to enhance the significance of the study.
>
> 1\) One of the major analyses is the comparison between brain ECs in vivo and in vitro. The authors show nicely that several genes that are activated by canonical Wnt signaling become downregulated within a week in culture. What specific culture conditions were used to culture mouse endothelial cells? Several key studies in the field of vascular biology have shown that addition of serum or ECGS in the media can affect the transcriptional landscape of ECs in culture. Therefore, the findings from the authors about the presence of differences are not surprising. However, can the authors perform a similar analysis using more defined conditions and various EC media to determine which conditions may provide the minimum divergence from the brain ECs? This will be highly valuable for vascular biologists and represent a major advancement in the field.

The CNS endothelial cells were cultured in Lonza's EGM-2 MV medium \[5% fetal bovine serum, VEGF, EGF, FGF, and IGF1\]. This is now described in greater detail in the Materials and methods section. Importantly, there was no genetic or pharmacologic treatment to activate canonical Wnt signaling, as described in Paolinelli et al., (2013)in vitro. The suggestion of additional studies with cultured CNS endothelial cells would represent a logical extension of the experiments and analyses described here but doing those additional experiments would represent a major endeavor and would -- in our view -- be beyond the scope of the present study.

> 2\) Does addition of Wnts or Wnt agonists to cultured brain ECs restores their properties to a certain extent or is the divergence in culture so extensive that is irreversible? When does this process become irreversible?

Yes, constitutively activating canonical Wnt signaling in cultured brain ECs gives them molecular and tight junction characteristics more in line with their in vivo counterparts (Paolinelli et al., 2013). As Paolinelli et al., showed, this can be done with Wnt ligands or Wnt-containing conditioned medium, but it was most effectively done by lentiviral transduction with a LEF/TCF derivative carrying the β-catenin transcriptional activation domain. We are not aware of any data that examines reversibility or irreversibility in cell culture, but earlier work from several groups (including ours) using Cre-lox mediated gene deletion or activation showed that the BBB remains plastic throughout life and that the BBB can be lost or restored in vivo in postnatal mice (e.g., Liebner et al., (2008); Wang et al., (2012)). To flesh out these issues, we have expanded our description in the Results section of what has been done previously.

> 3\) Several studies have shown that brain or lung ECs in culture retain some tissue-specific identity and expression of certain genes in culture. What happens to some of the BBB-specific genes in cultured brain ECs? The authors do not show in detail BBB specific genes.

For the analysis of in vivo vs. cultured ECs we have added the following. The new version of Figure 10 shows a plot of gene expression changes for 20 BBB-specific genes. Additionally, the new Figure 10---figure supplement 2 shows the in vivo vs. in vitro expression data for 9 Wnt signaling related or regulatory genes (e.g. Apcdd1 and Axin2) and 12 genes that code for membrane and intracellular mediators of Wnt signaling. We have also added a new file (Supplementary file 9) that lists the BBB genes that are suppressed in cultured ECs relative to in vivo ECs. Finally, we have added new data on adult brain ECs in vivo to expand the comparison with cultured brain ECs. In the original submission, all of the in vivo ECs were obtained at P7. The new data show that there is little difference when the comparison is performed with P7 or with adult ECs.

> 4\) Do lung ECs diverge to a \"generic\" EC when cultured for several days? It will be important to test this hypothesis and show the data for another cell type beside the CNS.

This is an interesting question for ECs from every organ, since distinctive organ-specific EC pattern of gene expression are presumably programmed (or at least influenced) by the tissue micro-environment. We have added several references to the existing data, although there is a dearth of published data addressing this question at the genome-wide level. However, we think that doing additional experiments to explore in vivo vs cultured EC properties beyond the basic characterization that we have performed with CNS ECs in culture would be a major undertaking and is beyond the scope of the current study.

> 5\) In Figure 7, the authors show some specific new markers for tip cells or capillary-A, capillary-V markers. A recent study by Betsholtz has shown that there is a zonal expression of several endothelial genes. Therefore, these findings are not surprising. Have the authors validated any of these markers in particular tip cell markers? They only show DCC. It will be important to validate other genes.

Additional validation is an excellent suggestion. We have performed in situ hybridization analyses on developing mouse retinas at P5-P7, when the annulus of tip cells is spatially distinct from the rest of the vascular plexus. This analysis has validated 3 novel tip cell genes that were predicted from our scRNA-seq and this new data is presented in a new figure (Figure 9).

> Reviewer \#3:
>
> Sabbagh et al. compare the transcriptional and epigenetic landscapes of endothelial cells in different organs: brain, liver, lung, and kidney. This is the first study to perform both RNA-seq, MethylC-seq and ATAC-seq of ECs in different organs, and the study also includes some brain EC vascular zonation analyses (a novel and timely topic). Lastly, the study compares expression of freshly isolated ECs and in vitro ECs cultured 8 days, but flaws exist with the design of this final experiment (see below comments). While the present study is interesting and has some novelty overall, the study could be improved by addressing the comments below:
>
> 1\) In vivo and in vitro transcriptional and epigenetic data (Figure 9 and Figure 10) are generated from two different strains of mice at two different developmental ages (in vivo: Tie2-GFP mice at P7; in vitro: C57BL/6 mice at P28-56); then the authors conclude from this data that in vitro culture affects gene expression. For this comparison to be valid, the authors should similarly analyze in vivo and in vitro cultured cells from the same genetic mouse strain at the same age, and then determine the degree to which in vitro culture shifts gene expression. The time in culture is also important as it might affect the results. For instance, after how many population doubling times EC were studied? With increased timing in culture ECs might turn towards senescent-like phenotype. It would be really cool to show for how long they can sustain close to their in vivo determine profile. This is also why comparing mice at similar age may be important especially as a recent study in Nature 2018 suggests that some endothelial cells do not fit the A-V zonation pattern and exhibit high expression of ribosomal protein transcripts, which indicates that protein synthesis occurs throughout the A-V axis.

As noted above in our reply to reviewer \#2, we agree that a more in-depth analysis of the in vivo vs. in vitro properties of CNS ECs would be very interesting and would represent a logical extension of the experiments and analyses described here but doing those additional experiments would represent a major endeavor in itself and would -- in our view -- be beyond the scope of the present study. That said, we agree that a comparison between adult CNS ECs in vivo and adult CNS ECs in vitro would be valuable. In the original submission, the comparison was with P7 ECs in vivo vs. adult ECs in vitro. Therefore, we have generated RNA-seq and ATAC-seq data sets from adult brain and repeated the in vitro vs. in vivo analyses with these datasets. The results are in close agreement with the P7 comparison and are shown in the new Figure 10 and Figure 11. See, for example, the heatmap in Figure 10B, the PCA in Figure 10C, and the expression profiles in Figure 10D.

> 2\) The entire study uses 2 biological replicates consisting of 2 total number of mice for liver, kidney and lung and 4 total mice (2 mice pooled per replicate) for brain transcriptional and epigenetic data (except brain ATAC-seq that was conducted with 3 biological replicates). We think that 2 biological replicates may not be sufficient.

The question of how many replicates to use for NextGen sequencing studies has been discussed by various authors (e.g. Liu, Zhou and White, 2014). We find that RNA-seq, ATAC-seq, and MethylC-seq give very good reproducibility between pairs of biological replicates, as shown by the scatter plots and R-values which are shown for each pair of replicate data reported here. For example, the inter-replicate R-values for the 4 EC types ranges from 0.91 to 0.95, whereas the R-values between different EC types ranges from 0.45 to 0.77. We do not think that adding a third biological replicate will change the analysis.

> 3\) The authors may consider developing a website to enable readers to more easily access the study\'s transcriptional and epigenetic data, as many other groups have done (see for example Zhang et al., 2014; He et al., 2016; Vanlandewijck et al., 2018).

This is a great suggestion, and we have now developed a user-friendly web site (using the ShinyApp platform) so that the scientific community can query our data. The link is: https://markfsabbagh.shinyapps.io/vectrdb/

> 4\) The manuscript\'s overall interpretation, readability and data presentation could be improved. For example, the authors present the degree of methylation of differentially expressed EC genes in each organ expressed as gene browser snapshot and bar/scatter plots (Figure 2---figure supplement 2), but no statistical analyses are performed, and the methylation pattern interpretation is not always clear. Moreover, the many gene browser snapshots presented throughout the figures are not reader friendly and do not clearly demonstrate the point the authors are trying to make in the text.

Thank you for that comment. We have gone through the text to try to improve readability. Part of the challenge is simply that there are a lot of data and a lot of analyses. We have also modified some of the browser images by adding arrows (and referring to the arrows in the text) -- this will make it easier for the reader to focus on the points of interest. Regarding the gene expression analyses in Figure 2---figure supplement 2C, each of these genes had been flagged in an initial comparison as differentially expressed at a statistically significant level. Furthermore, the DMVs indicated by colored bars in the browser images were called using appropriate statistical packages.

Regarding the barplot in Figure 2---figure supplement 2B, the reviewer is correct that there is no statistical analysis for the comparison between tissues because we could not figure out what a biological meaningful statistical analysis would consist of. The goal of this analysis was to highlight a trend that statistically significant DNA methylation valleys at statistically significant differentially expressed transcription factor genes exhibit differences in the size of the valley. Moreover, we think that the point is clear from inspection of the primary data: some TF genes (such as the ones shown in the top two rows of Figure 2D) overlap large regions of demethylation in all four EC types, and others (such as *Gata1, Spi1, Pou5f1* and *Tcf4* in the third row of Figure 2D) have essentially no demethylation. At present, all that we can say is that this is a striking observation in search of an explanation.

> 5\) In addition to reporting Gene Ontology (GO) pathways shared by brain, liver, lung and kidney (Figure 2---figure supplement 1E), the authors should also include GO pathways terms that are unique to ECs in each organ.

We have added this analysis (Gene Ontology for the four sets of ECTSGs) as File 3.

> 6\) The authors present heatmaps depicting gene expression and mean fraction of methylated CG in the gene body for genes within four HOX clusters presented anterior to posterior (Figure 3C). Many of the genes shown lack an association between high gene expression and high methylation or low gene expression and low methylation. What is the interpretation of this figure? This should be added and adequately discussed in the text.

We have expanded the Results section related to the Hox gene clusters to clarify the analysis, and we have added arrows to the genome browser images to more clearly connect text and figures. The reviewer is correct that the correlation between methylation and expression shows substantial variability across the four clusters -- the correlation is imperfect. Rather, like other developmentally important TFs, the trend appears to be that expression of a HOX gene corresponds to increased methylation upstream of the gene body. For example, *Hoxa5* whichis expressed in liver, lung, and kidney ECs but not brain ECs exhibits a hypomethylated gene body in all ECs but a hypermethylated promoter region in only peripheral ECs. The heat maps in Figure 3 present the basic correlation between organ position along the rostro-caudal axis, HOX gene expression, and HOX gene body methylation, but our simple analysis does not reflect the regulatory complexities of the HOX clusters, which are still not fully understood. The lack of an apparent association between high gene expression and high methylation is likely due to the calculation of methylation in the gene body. We have added to Figure 3 a summary heatmap of total methylation for each of the four HOX clusters for each of the tissue-specific ECs.

> 7\) It is quite surprising the authors do not cite a recent Nature paper that is the first to present transcriptional analysis of vascular zonation profiles of brain endothelial cells and mural cells (Vanlandewicjk et al., 2018). This paper should be cited and discussed. In regard to this paper and clustering of different brain endothelial types along the A-V axis -- arterial, capillary and venous (also shown in the authors Figure 7 and Figure 8), do the authors know which endothelial cell clusters are represented by their in vitro analysis? This also could be the source for variation between in vitro and in vivo findings, as in vitro ECs might have differentially enriched clusters of cells compared to in vivo, depending on the source of origin.

The Vanlandewicjk et al., paper appeared the week before we submitted our manuscript, when our text was in essentially its final form. We decided at that time to submit our manuscript without expanding the Discussion section to include an assessment of the Vanlandewicjk et al., data. We are pleased to now have an opportunity to include that assessment in an expanded Discussion section.

Regarding the different properties of CNS ECs in vivo vs in vitro, we have explored the origins of the in vitro CNS ECs (capillary, artery, vein, etc.) that we analyzed by assessing the abundances of the top 500 transcripts from each of the EC clusters defined by scRNA-seq. This new analysis (Figure 10---figure supplement 1) shows that the in vitro ECs have a gene expression profile that is a good match to all six scRNA-seq clusters. For at least the first two days the cultured ECs retained a core attribute of the BBB: an ability to extrude puromycin, thereby rendering them selectively resistant and allowing us to kill all of the non-ECs (neurons, glia, pericytes, etc.) in the culture. The ECs were cultured for 8 days before harvesting.

> 8\) The EC Methyl-seq correlation between different organs is very good: r=0.95-0.97 (Figure 2A; Figure 2---figure supplement 1B) and r=0.90-0.92 (Figure 4---figure supplement 3), compared to the EC RNA-seq (normalized counts) correlation between different organs (r=0.45-0.61) (Figure 1B). Why is this? The authors may want to elaborate on this in the discussion.

The higher correlation among methylomes largely reflects the inclusion of all genes (\>20,000) in the comparison, most of which are not differentially expressed and not differentially methylated. By contrast, the RNA-seq comparison was limited to EC-enriched genes -- thus, it did not include unexpressed genes or housekeeping genes. This is now described in the Results section.

> 9\) It would be helpful if the authors can provide quantification for their immunohistochemistry data (e.g., Figure 6).

That is a good idea. We have done this, and it has been added to the Results section and shown in a new supplemental Figure (Figure 6---figure supplement 2).

> 10\) This study only uses male mice. This is a limitation given the NIH\'s urge to be inclusive of both genders.

A good point. We used male mice to try to minimize any sex-dependent variability (which is likely modest compared to the inter-organ variability represented by BBB gene expression) and we could have just as easily used only female mice. This is a real conundrum because to do the studies in the most careful manner (as per the NIH) means analyzing both males and females and either pooling the data (with the attendant risks of increased biological variability) or doubling the number of mice, the amount of sequencing, and much of the costs. This highlights the advantages of working with a hermaphrodite like *C. elegans*!

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Thank you for resubmitting your work entitled \"Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells\" for further consideration at eLife. Your revised article has been favorably evaluated by Didier Stainier (Senior Editor), a Reviewing Editor, and two reviewers.
>
> All of the reviewers agree that the paper has been improved significantly after revision. However, some doubts still remain that need to be addressed before acceptance. These are related to the comparison of brain derived endothelial cells in vivo or in culture conditions in vitro.
>
> Specifically, a more accurate study on the culture conditions used seems important to draw conclusions. It has been known for many years that when brain endothelial cells are isolated and cultured they lose their BBB properties quite rapidly, unless they are maintained in co-culture with astrocytes (see, for instance, papers from R Cecchelli et al., and many others) or when Wnt is added to the medium. In addition, the extreme functional variability of endothelial cells derived from different vascular regions of the brain may further confuse the final results. For instance, when the cells have an arterial, venous or capillary origin or when they derive from vessels of different brain regions.
>
> The shared view of the reviewers is that, if the authors agree to drop these data (subsection "Rapid loss of the CNS EC transcriptional signature upon culturing of primary brain ECs" and Subsection "Changes in accessible chromatin in primary brain EC culture reflect loss of Wnt signaling" and related results), the paper would be more focused and solid and, overall, will add a lot to our understanding about the diversification of endothelial cells to distinct organ-specific identities.
>
> We hope that the authors accept to drop this part of the results so that the paper will be acceptable for publication in eLife. This conclusion was reached after lively and motivated discussion among the reviewers and the Editors.

We are happy to comply with your and the reviewers' judgment regarding manuscript changes, and we have, accordingly, removed the section of the manuscript (text and figures) dealing with cultured endothelial cells. The only substantive addition we have made is to note in the Results section that many ETS:ZIC paired motifs are found in the LTRs of a endogenous retrovirus family.
